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CHAPER 1: GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation contains 4 chapters.  Chapter 1 is a general introduction of the 
information related to the structural and functional studies of Mms6 protein 
presented in this dissertation.  A detailed literature review of magnetotactic bacteria 
and magnetotaxis is given first that is followed by an introduction of the formation 
of magnetosomes and bacterial magnetites.  The current understanding of Mms6 
protein and its function in bacterial magnetite formation is then discussed.  The 
chapter concludes with a general discussion of the other two major biomineralization 
systems in living organisms. 
Chapter 2 is a manuscript to be submitted to The Journal of Biological 
Chemistry.  In the manuscript, we reported biochemical and biophysical studies of 
the ferric ion binding pattern of Mms6 protein and reported the discovery of a slow 
conformational change of Mms6 upon binding of ferric ion.  A model of how 
Mms6 promotes formation of bacterial magnetic nanoparticles is proposed.  The 
co-authors are Lijun Wang (conducted most of the studies described in this 
manuscript and wrote the manuscript), Shuren Feng (conducted the time-dependent 
structural change studies of Mms6 protein upon ferric ion binding by fluorescence 
spectroscopy), Pierre Palo (Expressed and purified the protein samples used in this 
study), Bruce Fulton (conducted all the NMR spectroscopy studies) and Marit 
Nilsen-Hamilton (corresponding author, mentored Lijun Wang, Shuren Feng, 
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initiated the project, oversaw the project including data analysis and revised the 
manuscript). 
Chapter 3 is a manuscript prepared for the submission to The Journal of 
Biological Chemistry.  In this manuscript we reported that the formation of 
magnetic nanoparticle is associated with the periodical structural change that 
involves the quaternary structure of Mms6.  We also report the discovery of a ferric 
reductase activity of the C-terminus of Mms6 protein indicates that the reduction of 
ferric to ferrous iron maybe part of the mechanism of crystal packing.  The 
coauthors are Lijun Wang (studies of the quaternary structure of Mms6 and ferric 
reductase studies), Shuren Feng (all the fluorescence spectroscopy studies), Pierre 
Palo (expressed and purified the protein samples), Tanya Prozorov (TEM imaging 
and magnetic property measurements), Xunpei Liu (magnetite synthesis), Wenjie 
Wang and David Vaknin (surface fluorescence study and related data analysis), 
Bruce Fulton (NMR spectroscopy study), Surya Mallapragada (mentored Xunpei Liu 
and Tanya Prozorov, initiated and oversaw the TEM and polymer aspects of the 
project, PI on the grant funding the project) and Marit Nilsen-Hamilton 
(corresponding author, mentored Lijun Wang, Shuren Feng, initiated the project, 
oversaw the project including data analysis).  Contributions to the writing of the 
manuscript were made by Lijun Wang, Tanya Prozorov, Wenjie Wang and Marit 
Nilsen-Hamilton with the major contributions being by Lijun Wang and Marit 
Nilsen-Hamilton. 
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Chapter 4 is the general conclusions and perspective towards the future 
direction. 
Literature review 
Magnetoreception is a sensory system that provides the orientation, navigation, 
and homing traits for some creatures from bacteria to higher vertebrates (Kirschvink, 
Walker et al. 2001).  The physical basis of this response is thought to be the 
nanoparticles of single-domain magnetite (Diebel, Proksch et al. 2000).  These 
nanoparticles have been found in fish, pigeons, honeybees, and even in human brains 
(Kirschvink, Kobayashi-Kirschvink et al. 1992; Diebel, Proksch et al. 2000; 
Kirschvink, Walker et al. 2001).  It is believed that they are responsible for the 
direction-sensing behaviors of these organisms.  The mechanisms regarding 
biomineralization remain unclear and are under intensive investigation.   
Magnetite nanoparticles have been used for drug delivery, magnetic resonance 
imaging, and array-based assay (Valenti, Rampa et al. 1998; Osaka, Matsunaga et al. 
2006).  To provide effective nanoparticles for these applications, efforts have 
focused on their synthesis and characterization of such magnetite nanoparticles in gel 
matrices, from bacteria or using protein cages (Breulmann, Cöfen et al. 1998; 
Valenti, Rampa et al. 1998; Okuda, Iwahori et al. 2003).  These efforts are 
strengthened when the mechanism of nanoparticles formation is understood.  
Magnetotactic bacteria, which can synthesize magnetic nanoparticles in vivo, are 
ideal candidates for studying mechanism (s) of biomineralization.  
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Magnetotactic Bacteria and Magnetotaxis 
Many highly ordered mineralized structures created by living organisms are often 
hierarchical in structure with fundamental structural elements at nanometer scales.  
The ability to fabricate such fundamental structures independently of these organisms 
could open many new and exciting opportunities in nanotechnology.  Magnetotactic 
bacteria provide the ideal model for the studies of biomineralization mechanisms and 
biomimetic materials.   
Magnetotactic bacteria are aquatic prokaryotes that can orient themselves along 
the local geomagnetic field to find the optimal microaerobic environments for them to 
live.  The first report regarding magnetotactic bacteria was published in 1975 
(Blakemore 1975).  The first strain of magnetotactic bacteria reported was found in 
marine sediments.  The most intriguing feature of these bacteria is the ability of 
moving in a magnetic field as weak as 0.5 gauss (Blakemore 1975; Blakemore, 
Maratea et al. 1979).  
After the discovery of the first magnetotactic bacterial strain, a series of 
magnetotactic bacterial strains have been reported from marine and fresh water 
(Blakemore, Maratea et al. 1979; Frankel, Blakemore et al. 1979; Blakemore 1982; 
Schüler 2008).  The cellular morphologies of magnetotactic bacteria vary from 
“cocoid, rod-shaped, helical to even multicellular” (Blakemore 1982; Bazylinski and 
Frankel 2004).  
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Despite the diversity of cellular morphologies, magnetotactic bacteria share some 
common features: All magnetotactic bacteria reported to date are gram-negative 
bacteria. They have flagella and can move under the direction of the local 
geomagnetic field.  They all have unique intracellular compartments, which are the 
magnetosomes.  When moving, all magnetotactic bacteria have a migration 
preference for a low oxygen concentration environment (Bazylinski and Frankel 
2004). 
Magnetotactic bacteria discovered to date fall into three general categories: 
Obligate microaerophiles, anaerobes or both (Bazylinski and Frankel 2004).  In an 
aqueous environment, they constitute a large portion of the bacterial population in the 
oxic-anoxic interface (Frankel, Bazylinski et al. 1997; Bazylinski and Frankel 2004).  
Magnetotactic bacteria are very sensitive to the environmental oxygen concentration 
and most of them can only synthesize magnetosomes in a very narrow range of low 
oxygen concentrations: Generally, if the initial oxygen concentration in the 
atmosphere of sealed cultures is higher than 6%, these bacteria cannot synthesize 
magnetites (Blakemore, Maratea et al. 1979; Frankel, Blakemore et al. 1979; 
Bazylinski and Frankel 2004).  This fastidious growth requirement of magnetotactic 
bacteria has limited the progress in this research field for many years and the number 
of pure cultured strains is still very small (Bazylinski and Frankel 2004). 
The term ‘magnetotaxis’ was first used by R.P. Blakemore to describe the 
responses of magnetotactic bacteria to external magnetic fields (Blakemore 1982).  
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As Blakemore claimed, “The term of magnetotactic bacteria is only a descriptor and 
has no taxonomic meaning.  Magnetotaxis denotes cell mobility directed by a 
magnetic field” (Blakemore 1982).  In fact, the response of magnetotactic bacteria to 
external magnetic fields can be more accurately described as ‘magneto-aerotaxis’ 
rather than ‘magnetotaxis’ (Frankel, Bazylinski et al. 1997).  As the term 
magneto-aerotaxis implies, the magnetic response of magnetotactic bacteria to the 
external field aligns cells along the magnetic field line, while the sensitivity of cells to 
the oxygen concentration or redox gradients determines the direction of their 
migration (Frankel, Bazylinski et al. 1997; Komeili 2007).  Now, the term 
magnetotaxis is used as an abbreviation of magneto-aerotaxis. 
Since the report of the first magnetotactic bacterial strain (Blakemore 1975), 
different strains of magnetotactic bacteria have been found globally.  Different 
strains of magnetotactic bacteria exhibit interesting migration patterns under local 
geomagnetic fields: Magnetotactic bacteria discovered in the Northern Hemisphere 
have a preferred migration pattern parallel to the magnetic field, exhibit a northward 
migration in the geomagnetic field, and are termed north-seeking (NS) magnetotactic 
bacteria (Blakemore 1975).  Magnetotactic bacteria discovered in the Southern 
Hemisphere have a preferred migration pattern anti-parallel to the magnetic field, 
exhibit a southward migration in the geomagnetic field, and are termed south-seeking 
(SS) magnetotactic bacteria (Blakemore, Frankel et al. 1980).  Amongst the 
magnetotactic bacteria discovered in the environments near the geomagnetic equator, 
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both south-seeking and north-seeking magnetotactic bacteria are equally distributed 
(Frankel, Blakemore et al. 1981). 
To explain these observations of north and south seeking bacteria, Blakemore 
proposed the original model of magnetotaxis: The geomagnetic field line is tilted 
downward from the horizon in the Northern Hemisphere and upward in the Southern 
Hemisphere.  Therefore, NS magnetotactic bacteria in the Northern Hemisphere and 
SS magnetotactic bacteria in the Southern Hemisphere actually both move downwards 
along the tilted geomagnetic field lines.  Magnetotaxis provide the guidance for the 
migration of cells to low oxygen concentration sediments, where they are believed to 
stop swimming and adhere to the sediment particles (Blakemore 1975; Blakemore 
1982; Bazylinski and Frankel 2004).  This hypothesis is consistent with the 
distribution of NS and SS magnetotactic bacteria on the geosphere (Blakemore 1975; 
Blakemore, Frankel et al. 1980; Frankel, Blakemore et al. 1981; Bazylinski and 
Frankel 2004). 
However, this original model regarding magnetotaxis in magnetotactic bacteria 
has some drawbacks: First, this hypothesis did not give a convincing explanation for 
the benefit magnetotaxis can bring to the magnetotactic bacteria in anoxic aqueous 
environments.  Second, this hypothesis cannot explain how magnetotactic coccoid 
bacteria form microaerophilc bands in semi-solid, oxygen-gradient media (Bazylinski 
and Frankel 2004).  The facts that large populations of magnetotactic bacteria are 
discovered at the ‘oxic-anoxic’ interface of aqueous environment and some 
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magnetotactic coccoid bacterial strains are obligate microaerophiles (Blakemore, 
Frankel et al. 1980; Frankel, Bazylinski et al. 1997) led to the birth of the term 
‘magneto-aerotaxis’, which is thought to be a more accurate description of the unique 
trait of magnetotactic bacteria (Frankel, Bazylinski et al. 1997).  In the proposed 
‘magneto-aerotaxis’ model, the magnetotactic bacteria use a two-state sensor 
machinery to regulate the sense of flagellar rotation (clockwise or counterclockwise) 
and therefore determine the direction of motion in response to lower or higher oxygen 
concentration (Frankel, Bazylinski et al. 1997; Faivre and Schüler 2008).  This 
two-state sensor machinery is clearly more efficient than the conventional 
‘run-and-tumble’ motion used by E.coli and other nonmagnetic bacteria in response to 
a vertical oxygen gradients found in chemically stratified sediments or water bodies 
(Smith, Sheehan et al. 2006; Faivre and Schüler 2008).  Although this model has 
been experimentally proven for magnetic coccus strain MC-1 which can migrate in 
either direction along the external magnetic field to find and maintain their position at 
their preferred oxygen concentration (Frankel, Bazylinski et al. 1997), it is still 
unclear whether this model applies to all the magnetotactic bacteria. 
In their report describing the magneto-aerotactic trait of magnetotactic bacteria, 
Frankel et al. investigated the migration patterns in capillary tubes of various strains 
of NS magnetotactic bacteria in oxygen-concentration gradients.  The results 
showed the joint effects of magnetotaxis and aerotaxis in the magnetotactic bacterial 
strains investigated (Frankel, Bazylinski et al. 1997).  In an aqueous environment, 
9 
these magnetotactic bacteria usually migrate towards one direction (north).  
However, these NS magnetotactic bacteria reversed the direction of their movements 
towards the higher oxygen concentration when they were put in an oxygen 
concentration lower than the optimal oxygen concentration required for their growth 
(Frankel, Bazylinski et al. 1997; Bazylinski and Frankel 2004). 
The current explanation of the function and mechanism of magnetotaxis is that 
magnetotactic bacteria use magnetosomes aligned in chains inside themselves to act 
as compass needles to direct their migration downwards along the tilted geomagnetic 
line to find the optimal microaerobic or anaerobic environment for their growth.  The 
magnetotactic trait of magnetotactic bacteria can simplify their search for the 
preferred microaerobic or anaerobic condition to a two dimensional rather than a 
random three dimensional search (Blakemore 1975; Frankel, Bazylinski et al. 1997; 
Bazylinski and Frankel 2004; Komeili 2007).  Recent results also demonstrated that 
magnetotactic bacteria move more quickly and efficiently towards the preferred 
microaerobic or anaerobic in an applied magnetic field (Smith, Sheehan et al. 2006).  
Recently, a novel species of SS magnetotactic bacteria has been found in the 
Northern Hemisphere (Simmons, Bazylinski et al. 2006).  Magnetotactic bacteria 
with opposing polarities were found coexisting in the same redox environment found 
in the Northern Hemisphere and the percentage of magnetotactic bacteria with the 
south-seeking migration pattern increases with redox potential (Simmons, Bazylinski 
et al. 2006).  These south-seeking magnetotactic bacteria found in the Northern 
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Hemisphere move upwards along the geomagnetic field lines and towards a higher 
oxygen level which is away from their preferred microaerobic oxygen environments 
and is opposite to all previously reported magnetotactic bacterial strains (Simmons, 
Bazylinski et al. 2006).  The exact function and mechanism of magnetotaxis trait in 
magnetotactic bacteria need further investigation and study. 
Magnetosome and Bacterial Magnetite 
The magnetosome, another intriguing feature of magnetotactic bacteria, is 
believed to be the biological basis of the intriguing magnetotactic trait of 
magnetotactic bacteria.  It is even more intriguing in the sense of a prokaryotic 
intracellular compartment (Murat, Byrne et al. 2010).  Magnetosomes, the very 
unique intracellular structures found in all magnetotactic bacteria, are vesicles each 
with a magnetite nanocrystal (usually 35 ~ 120 nm in diameter) inside and a lipid 
bilayer membrane with similar composition as the cytoplasmic membrane (Balkwill, 
Maratea et al. 1980; Bazylinski and Frankel 2004; Komeili 2007).  These vesicles 
are organized into chains by cytoskeletal filaments and fixed inside the cells 
(Komeili 2007).  The magnetite nanoparticles are the physical basis of the 
magnetotactic trait and the chain alignment of the magnetosome vesicles is the 
biological basis for this trait (Frankel and Bazylinski 2006; Komeili 2007).   
The term ‘magnetosome’ was first used by Balkwill et al. to describe “the 
electron-dense particles and their associated bounding layers in magnetotactic 
bacteria” (Balkwill, Maratea et al. 1980).  In this report, the authors observed that 
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the bacterial magnetites were surrounded by electron-dense layers and speculated 
that it is a true biological membrane and led to the birth of the term ‘magnetosome’ 
(Balkwill, Maratea et al. 1980).  The authors claimed that individual magnetosomes 
are linked together to form a chain.  The magnetosome chain is fixed to the inner 
cytoplasmic membrane of the cell (Balkwill, Maratea et al. 1980).  
Characterization of the magnetosome membrane was first reported in 1988 by 
Gorby et al. (Gorby, Beveridge et al. 1988).  The magnetosome membrane in 
Magnetospirillum maglonetotacticum strain MS-1 is a lipid bilayer with a 3 - 4 nm 
thickness.  The components of magnetosome membranes are mainly phospholipids, 
fatty acids and some proteins, which are similar to those found in the cytoplasmic 
membranes of magnetotactic bacteria (Gorby, Beveridge et al. 1988).  
Although the observation that the magnetosome membrane has a similar 
composition to the cytoplasmic membrane indicates that the magnetosome 
membrane may originate from the cytoplasmic membrane, there was no clear and 
conclusive experimental report regarding the molecular mechanism of magnetosome 
formation until recently (Komeili, Vali et al. 2004; Komeili, Li et al. 2006; Scheffel, 
Gruska et al. 2006). 
One critical question regarding magnetosomes in magnetotactic bacteria since 
their discovery about 30 years ago is how magnetosome vesicles are formed and 
aligned into chains.  It has been long speculated that the formation and chain 
alignment of magnetosome vesicles are under genetic control (Bazylinski, Frankel et 
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al. 1995; Frankel and Bazylinski 2006).  However, the systematic and detailed 
investigation of the molecular mechanisms of magnetosome formation was difficult 
until recently when the genomes of several magnetotactic bacteria, Magnetospirillum 
magneticum strain AMB-1 (Matsunaga, Okamura et al. 2005), Magnetospirillum 
gryphiswaldense strain MSR-1 (Richter, Kube et al. 2007), Magnetospirillum 
magnetotacticum strain MS-1 (Joint Genome Institute, 
http://genome.jgi-psf.org/draft_microbes/magma/magma.home.html), and 
Magnetospirillum magneticum strain MC-1 (Joint Genome Institute, 
http://genome.jgi-psf.org/draft_microbes/magm1/magm1.home.html), were 
sequenced and annotated (Richter, Kube et al. 2007). 
The comparative genomic analysis of these four magnetotactic bacteria reveals 
that a magnetobacterial core genome of about 891 genes was shared by all four 
magnetotactic bacteria (Richter, Kube et al. 2007).  Among these genes, 28 genes 
were identified as magnetotactic bacteria-specific genes.  These genes include all 
mam (magnetosome membrane) and mms (magnetic particle membrane specific) 
genes (Richter, Kube et al. 2007; Faivre and Schüler 2008; Schüler 2008).  In 
Magnetospirillum magneticum strain AMB-1, all these conserved 28 genes are 
located within a 130 kb genomic magnetosome island (MAI) which contains the 
majority of magnetosome protein genes, a high percentage of transposase genes and 
many hypothetical genes (Schübbe, Kube et al. 2003; Ullrich, Kube et al. 2005; 
Schüler 2008).  
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In 2004, Komeili et al. used the Magnetospirillum magneticum strain AMB-1 as a 
model system for magnetotactic bacteria and clearly demonstrated that magnetosome 
vesicles are present before magnetite formation, and that the protein MamA is 
required for their formation (Komeili, Vali et al. 2004).  By using 
cryo-ultramicrotomy, the authors observed intact chains of empty magnetosome 
vesicles in magnetotactic bacteria cultured under iron-limited conditions.  The result 
demonstrated that magnetosome vesicles are formed and aligned into chains before 
magnetite synthesis.  Deletion of the mamA gene, a gene encoding magnetosome 
protein MamA, resulted in shorter magnetosome chains (1-5 vesicles per cell) being 
synthesized inside the cells.  Two possible functions of the protein MamA in 
magnetosome formation were proposed: One function of MamA is that it may be 
involved in magnetosome assembly.  Another possibility is that MamA may be used 
by magnetotactic bacteria to control the number of magnetosome vesicles they 
synthesize and therefore the length of magnetosome chains when there is not enough 
iron available (Komeili, Vali et al. 2004). 
In 2006, two research groups reported the functions of protein MamJ and MamK 
in magnetosome formation in two different Magnetospirillum strains using essentially 
the same approaches and techniques.  Komeili et al. investigated the functions of the 
magnetosome protein MamK in magnetosome formation in the Magnetospirillum 
magneticum strain AMB-1 (Komeili, Li et al. 2006).  The authors used electron 
cryotomography (ECT) to study magnetosome formation. When cells were grown in 
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iron-limited conditions, empty magnetosome chains were observed (Komeili, Li et al. 
2006).  The ECT images clearly showed that about 34 % of the magnetosome 
vesicles were invaginations of the inner membrane and that the remaining 66 % were 
located close enough to the membrane to be the results of invaginations (Komeili, Li 
et al. 2006).  These results demonstrated that magnetosome vesicles originate from 
the invagination of the inner cytoplasmic membranes of the cells.  Deletion of the 
mamK gene, a gene encoding the magnetosome protein MamK, disrupted the 
magnetosome chains and the magnetosome vesicles were dispersed in the cells 
(Komeili, Li et al. 2006).  Complementation of the ∆mamK mutant with mamK–GFP 
restored the magnetosome chains (Komeili, Li et al. 2006).  The authors thus 
proposed that the protein MamK may form cytoskeletal filaments that align individual 
magnetosome vesicles into chains that are fixed in the cell (Komeili, Li et al. 2006).  
Later, by using immunogold staining and fluorescence microscopy, Pradel et al. 
demonstrated the authenticity of the MamK filaments and found that the MamK alone 
can form straight filaments in Escherichia coli (Pradel, Santini et al. 2006). 
Scheffel et al. investigated the role of the other acidic magnetosome protein 
MamJ in the formation of magnetosomes in Magnetospirillum gryphiswaldense 
(Scheffel, Gruska et al. 2006).  In the deletion mutant of mamJ, the magnetosome 
vesicles clustered together and no longer formed chains.  By using mamJ-eGFP and 
electron cryotomography (ECT), the authors demonstrated that the MamJ protein was 
localized adjacent to a filament that extended through the length of cell.  When cells 
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were cultured under iron-insufficient conditions, empty magnetosome vesicles linked 
to the linear filament were observed in wild type cells.  However, in ∆mamJ mutants, 
empty vesicles were dissociated from the filaments when cultured with insufficient 
iron (Scheffel, Gruska et al. 2006).  The authors proposed a model for magnetosome 
chain formation: First MamJ links empty magnetosome vesicles to the cytoskeletal 
filaments formed by MamK inside cells.  Then magnetite particle synthesis initiates 
inside the vesicles.  As the magnetite particles continue to grow, the magnetic 
moments between the particles start to take effect and bring them together, forming 
stable magnetosome chains (Scheffel, Gruska et al. 2006). 
Nearly 35% of all proteins associated with the magnetosome membrane of 
Magnetospirillum gryphiswaldense are MamGFDC proteins (Grünberg, Müller et al. 
2004).  Recent deletion mutagenesis and complementary analysis of mamGFDC 
operon demonstrated that these major magnetosome membrane proteins are not 
essential for the biomineralization of bacterial magnetites, but control the size of 
magnetites (Scheffel, Gardes et al. 2008).  The deletion of mamGFDC operon failed 
to completely abolish the formation of bacterial magnetites in Magnetospirillum 
gryphiswaldense.  In the deletion mutant of mamGFDC, the magnetites formed were 
only 75% of the wild-type size with irregular morphology.  The complementation of 
the deletion mutant with one, two, and three genes of the mamGFDC operon 
gradually restored the formation of wild-type size bacterial magnetites.  The authors 
thus proposed that the MamGFDC proteins may have partially redundant functions 
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and control the size of magnetite crystals in a cumulative way (Scheffel, Gardes et al. 
2008).  The mechanism of this process remains unclear. 
In a recent review, Komeili proposed the molecular mechanism of magnetosome 
formation in the Magnetospirillum magneticum Strain AMB-1 (Komeili 2007).  
This model involves three steps: First, membrane invagination occurs at the inner 
part of the cytoplasmic membrane of the magnetotactic bacteria.  Second, 
individual invaginations are assembled into a chain by MamK and MamJ.  Third, 
iron is transported into the magnetosome vesicles and the synthesis of magnetite 
nanocrystals with defined structures is stimulated by Mms6 (Bazylinski and Frankel 
2004; Komeili 2007).  Recent comprehensive functional analysis of the mamAB 
gene cluster in Magnetospirillum magneticum strain AMB-1 identified addition 
proteins participated in the formation of magnetosome and confirmed that the 
formation of magnetosome is a step-wise process under strict genetic control (Murat, 
Quinlan et al. 2010).  The formation of magnetosome starts with the invagination of 
cytoplasmic membrane which requires the action of MamI, MamL, MamQ and 
MamB proteins.  Then the chain assembly of individual invaginations was 
accomplished by MamK and MamJ protein.  MamM, MamN and MamQ proteins 
appear to participate in the iron uptake process.  The size and morphology of 
bacterial magnetites seem to be under the control of MamGFDC and Mms6 proteins 
(Arakaki, Webb et al. 2003; Scheffel, Gardes et al. 2008; Murat, Quinlan et al. 2010).  
In the current model, evidence regarding membrane invagination and magnetosome 
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vesicle assembly is convincing, but the mechanism of Mms6 stimulated bacterial 
magnetites formation inside magnetosome vesicles remains unclear. 
The chain alignment of the magnetite nanoparticles formed inside the 
magnetosome vesicles by magnetotactic bacteria is thought to be the physics basis of 
the magnetotactic trait of magnetotactic bacteria (Penninga, de Waard et al. 1995; 
Dunin-Borkowski, McCartney et al. 1998; Bazylinski and Frankel 2004).  The 
magnetite particles
 
synthesized by magnetotactic bacteria have high chemical purity.  
It is the first direct evidence to demonstrate that the presence of magnetites in living 
organisms may participate in their responses to external magnetic fields (Frankel, 
Blakemore et al. 1979; Bazylinski and Frankel 2004). 
The size of magnetite crystals synthesized by magnetotactic bacteria is within the 
single-magnetic-domain (SD) size range (Dunlop 1973; Butler and Banerjee 1975).  
Magnetite particles within the SD size range are permanently magnetic and the 
magnetic moments remain stable in ambient environments (Bazylinski and Frankel 
2004; Komeili 2007).  Magnetite particles smaller than the SD size are 
superparamagnetic and their magnetic moments are not permanent in ambient 
environments (Bazylinski and Frankel 2004).   
Under transmission electron microscopy (TEM), the magnetite particles 
synthesized by magnetotactic bacteria can be seen as chain(s) within the cell 
(Blakemore 1975; Frankel, Blakemore et al. 1979; Bazylinski and Frankel 2004).  In 
the first paper investigating the physical properties of bacterial magnetite particles, the 
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authors assumed that the total magnetic moments of the whole cell were the sum of 
the magnetic moments of individual SD magnetic particles and had a calculated 
magnetic moments as 1.3X10-12 electromagnetic units, which provided enough 
magnetic moment for cells to align themselves along geomagnetic field lines as low 
as 0.5 gauss (Frankel, Blakemore et al. 1979).  Subsequent light-scattering 
measurements of magnetic-moment of the Magnetospirillum magnetotacticum strain 
MS-1 (Rosenblatt, Dearaujo et al. 1982), remanence measurements on individual 
Aquaspirillum magnetotacticum ATCC 31632 (Penninga, de Waard et al. 1995) and 
magnetic force microscopy of the submicron magnetic assembly of the marine 
magnetotactic vibrio strain MV-1 (Proksch, Schaffer et al. 1995) confirmed this 
calculation.  It has been concluded that the magnetite particles synthesized by 
magnetotactic bacteria, aligned into chain(s) that are fixed within cells, act as “tiny 
compass needles” to direct the migration of magnetotactic bacteria (Bazylinski and 
Frankel 2004).  It is the chain-aligned magnetite particles fixed inside the cells that 
confer the magnetotactic trait on magnetotactic bacteria. 
Definitive studies of the chemical composition of magnetite particles synthesized 
in magnetotactic bacteria had not been possible until the first pure culture of 
magnetotactic bacteria, Magnetotactic Spirillium strain MS-1, was isolated in 1979 
(Blakemore, Maratea et al. 1979).  By using Mössbauer spectroscopy, Frankel et al. 
clearly demonstrated that the iron-containing mineral synthesized inside 
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Magnetotactic Spirillium strain MS-1 is ferromagnetic Fe3O4 with an average size 
(maximum dimension) of about 50 nm (Frankel, Blakemore et al. 1979).  
Magnetotactic bacteria usually synthesize ferricmagnetic magnetites (Fe3O4).  
But it has also been reported that in some magnetotactic bacteria, which were 
discovered in sulphide rich aqueous environments, the iron mineral crystals are 
present in the form of ferricmagnetic greigite (Fe3S4) (Farina, Esquivel et al. 1990; 
Mann, Sparks et al. 1990).  The compositions of iron mineral crystals are strain 
specific and under strict control by the bacteria (Bazylinski and Frankel 2004).  
Meldurm and colleagues demonstrated that two cultured magnetotactic bacterial 
strains, MC-1 and MV-2, which synthesize magnetites inside their magnetosome 
vesicles, continue to synthesize Fe3O4 instead of Fe3S4 even when hydrogen sulphide 
was supplied in the culture medium (Meldrum, Mann et al. 1993; Meldrum, Mann et 
al. 1993).  Only one magnetotactic bacterial strain has been reported that can 
synthesize both magnetite (Fe3O4) and greigite (Fe3S4), but the pure culture of this 
magnetotactic bacterium has not yet been isolated (Bazylizinki, Heywood et al. 1993; 
Bazylinski, Frankel et al. 1995; Bazylinski and Frankel 2004).  
Usually, the size of Fe3O4 or Fe3S4 synthesized by magnetotactic bacteria ranges 
from 35 nm to 120 nm but is consistent within each species or strain of magnetotactic 
bacterium (Bazylinski, Garrattreed et al. 1994).  The morphologies of the mineral 
crystals reported to date fall into three general categories: “roughly cuboidal, 
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elongated prismatic (roughly rectangular), and tooth-, bullet- or arrowhead-shaped” 
(Bazylinski and Frankel 2004). 
Little is known about the real process and mechanism of magnetite particle 
synthesis inside magnetotactic bacteria.  It has been proposed that it may involve 
three stages (Frankel, Papaefthymiou et al. 1983; Bazylinski, Frankel et al. 1995; 
Bazylinski and Frankel 2004): First, ferric ions are taken up by the cells through some 
specific iron transport systems and then reduced to ferrous ions and transported into 
the magnetosome vesicles where the magnetite particles are synthesized.  Second, 
ferrous ions are reoxidized to ferric ions and form hydrous ferric oxides.  The final 
stage is reducing one-third of the ferric ions in ferric oxides into ferrous ions and then 
transforming the hydrous iron oxides into magnetite nanoparticles with defined 
uniform structures.  
From the currently available information, it seems that different magnetotactic 
bacterial strains adopt different strategies to transport iron into magnetosome vesicles 
in different redox forms. In the Magnetospirillum magneticum Strain AMB-1, it has 
been reported that iron is transported into magnetosome vesicles in the form of Fe 
(III). The protein Mag A, which is believed to be a homolog of the cation-efflux 
protein Kef C in Escherichia coli, is involved in iron transport in the 
Magnetospirillum magneticum Strain AMB-1 (Nakamura, Burgess et al. 1995).  
Studies on iron transport in the Magnetospirillum magnetotacticum strain MS-1 
demonstrated that Fe (II) is transported into magnetosome vesicles with the aid of 
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siderophores (Paoletti and Blakemore 1986).  In the Magnetospirillum 
gryphiswaldense Strain MSR-1, evidence showed that both ferric and ferrous iron can 
be taken up into magnetosome vesicles (Schüler and Baeuerlein 1998; Bazylinski and 
Frankel 2004). 
Recently, Faivre et al. systematically studied the magnetite biomineralization 
pathway in Magnetospirillum gryphiswaldense Strain MSR-1 (Faivre, Böttger et al. 
2007).  The results showed iron was taken up from the environment either as ferric 
or ferrous ion into the cell through the cytoplasmic membrane of Magnetospirillum 
gryphiswaldense Strain MSR-1.  Then a pool of ferric and ferrous iron was then 
formed at cytoplasmic membrane.  The ferric iron was chelated by some unknown 
organic substrate, while the ferrous iron was sequestered in membrane associated 
bacterial ferritin.  The ferric and ferrous iron then were released and transported into 
the invaginated magnetosome vesicles by mechanisms as yet unknown.  The 
magnetite formation then was initiated by the fast coprecipitation of ferric and ferrous 
ions without any precursor phase.  The growth and maturation of magnetites appears 
to be completed in the magnetosome vesicles and controlled by other proteins (Faivre, 
Böttger et al. 2007).  It is unclear whether this magnetite biomineralization process is 
universal to all magnetotactic bacteria species. 
 However, another study of the formation of magnetosome in Magnetospirillum 
gryphiswaldense Strain MSR-1 showed contrary results (Staniland, Ward et al. 2007).  
The magnetosome materials of Magnetospirillum gryphiswaldense Strain MSR-1 was 
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investigated in vivo by real-time x-ray magnetic circular dichroism.  The authors 
reported the observation of the formation of full size nanocrystal with nonmagnetic 
surface layers constituted by hematite (the nonmagnetic precursor of magnetite) 
within 15 minutes after the formation was initiated.  The transformation of hematite 
to mature magnetite nanoparticles was completed within another 15 minutes.  The 
fact that bacteria only take 30 minutes to synthesize the magnetites suggests that this 
process may be catalytic as proposed by the authors (Staniland, Ward et al. 2007). 
Mms6 Protein and Biomineralization 
Mms6, a magnetosome-associated protein, may be the most intriguing protein 
found in the magnetosome.  The Mms6 protein was first reported by Arakaki et al. 
as a magnetosome membrane-associated protein which is tightly bound to magnetite 
nanoparticles isolated from the Magnetospirillum magneticum strain AMB-1 
(Arakaki, Webb et al. 2003).  In their report, Arakaki et al. identified several small 
proteins, Mms5, Mms6, Mms7, Mms13 that were tightly bound to the bacterial 
synthesized magnetite nanoparticles.  The most intriguing feature of Mms6 protein 
is its ability to promote the formation in vitro of magnetite nanoparticles with the 
similar size and morphology as those made by magnetotactic bacteria (Arakaki, 
Webb et al. 2003). 
Mms5, Mms6, Mms7 and Mms13 have been categorized as proteins tightly 
bound to the bacterial magnetite nanoparticles.  These small proteins are encoded 
by the mamCD and mms6 gene clusters, which are adjacent to each other in the 
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Magnetospirillum magneticum strain AMB-1 genome (Grünberg, Wawer et al. 2001; 
Komeili 2007).  Mms5, Mms6 and Mms7 share some common features: They all 
have a hydrophobic N-terminal domain, which is proposed to be the membrane 
domain of these proteins, and a hydrophilic C-terminal domain, which may be 
involved in magnetite nanoparticle formation.  Only Mms6 has been reported to 
promote the formation of magnetite nanoparticles with similar morphology to 
bacterial magnetites in vitro by co-precipitation of ferric and ferrous ion (Arakaki, 
Webb et al. 2003).  But the critical magnetization measurements and structural 
characterizations of these magnetite particles synthesized in the present of 
recombinant Mms6 protein were lacking in this report. 
In 2007, Prozorov et al. reported magnetization measurements and structural 
characterization of magnetite nanoparticles synthesized in the presence of 
recombinant Mms6 protein (Prozorov, Mallapragada et al. 2007).  The Mms6 
protein was expressed as recombinant protein with a poly-His tag attached to its 
N-terminus.  Genomic DNA was obtained from Magnetospirillum magneticum 
strain AMB-1.  The DNA was amplified using primers that are complementary to 
internal sites on the Mms6 gene coding region.  The genomic DNA was amplified 
using primers that are complementary to internal sites on the Mms6 gene coding 
region.  The primers were designed to amplify the region of the gene corresponding 
to the mature Mms6 protein.  The polymerase chain reaction (PCR) amplicon was 
cloned into the plasmid pTrcHis TOPO.  This cloned expression vector was used to 
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prepare recombinant mature Mms6 protein.  Cells of E.coli transformed by Mms6 
expression vectors were used to produce His-tagged Mms6.  A large fraction of the 
expressed Mms6 was present in inclusion bodies.  The inclusion bodies were 
dissolved in 8 M urea, and purified by TALON column which specifically binds 
histidine.  The captured His-Mms6 protein was refolded by sequential dialysis 
against increasingly lower concentrations of urea in 20 mM Tris, 500 mM KCl, 0.2 
mM phenylmethanesulfonyl fluoride, 1 mM EDTA, pH 7.5.  The His-Mms6 was 
then dialysis against 2 changes of 20 mM Tris, 100 mM KCl, pH7.5.  BSA, ferritin 
and Lcn2 were used as controls to compare magnetite particles synthesized in the 
presence of proteins with different iron binding properties.  The X-ray powder 
diffraction pattern of the His-Mms6 derived particles identified them as magnetites.  
The magnetization measurements and transmission electron microscopy results 
showed that magnetite particles with defined structures can only be synthesized 
when Mms6 is present (Prozorov, Mallapragada et al. 2007).  
Mms6, or its C-terminal part, promotes the synthesis of cobalt ferrite 
nanoparticles, which are not known to be present in any living organism  (Prozorov, 
Palo et al. 2007).  The authors covalently attached His-Mms6 or the C-terminal part 
of Mms6 to self-assembling polymers and used the resulting polymers as templates to 
synthesize cobalt ferrite nanocrystals.  The resulting cobalt ferrite nanocrystals 
exhibited 50 - 80 nm thin hexagon-like structures that are difficult to produce using 
conventional techniques.  The authors proposed that when the self-assembling 
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polymers were covalently attached with His-Mms6 or its C-terminal part, they may 
act in a manner similar to the bacterial magnetosome membranes and allow a 
surface-controlled crystal growth (Prozorov, Palo et al. 2007). 
Amemiya et al. reported the synthesis of magnetite nanoparticles by partial 
oxidation of ferrous hydroxide in the presence of Mms6 (Amemiya, Arakaki et al. 
2007).  The results showed that cubo-octahedral magnetites with narrow size 
distribution were formed after ferrous hydroxides were partially oxidized at 90 ℃?  in 
the presence of Mms6 for 4 h.  While in the absence of Mms6, only octahedral 
magnetites with broad size distribution were formed under the same experimental 
conditions.  The authors thus proposed that Mms6 may control the morphology of 
magnetite to be specifically cubo-octahedral by binding to the specific crystal face of 
the magnetites thus control the growth of magnetites in the above in vitro synthesis 
(Amemiya, Arakaki et al. 2007).  
A study in Magnetospirillum magnetotacticum strain MS-1 showed that the 
cubo-octahedral morphology of MS-1 bacterial magnetites can be disturbed when the 
cells are grown in the presence of Ni.  The cellular content of Mms6 in this case was 
also decreased.  The correlation between the morphology of magnetites and the 
cellular content of Mms6 indicated that the role Mms6 in vivo may be to control the 
growth of bacterial magnetic nanoparticles (Kundu, Kale et al. 2009).  The exact 
effect of Ni on cellular Mms6 content remains unclear. 
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Recently, Tanaka et al. reported the in vivo study of the effect of Mms6 on the 
formation bacterial magnetites in Magnetospirillum magneticum strain AMB-1 
(Tanaka, Mazuyama et al. 2011).  In the deletion mutant of the mms6 gene (∆mms6), 
only smaller size bacterial magnetites with uncommon crystal faces were observed.  
While the complementation strains of ∆mms6 mutant synthesized magnetites similar 
with the wild type with uniformed cubo-octahedral morphorlogy (Tanaka, 
Mazuyama et al. 2011).  This is the first in vivo study that clearly demonstrated that 
Mms6 can control the morphology and size of bacterial magnetites.  Interestingly, 
deletion of the mms6 gene resulted in a significant decrease of the amount of Mms5, 
Mms7, and Mms13 on the surfaces of bacterial magnetites.  The authors thus 
proposed that Mms6 may serve as a scaffold protein to form a protein complex with 
other Mms proteins and co-locate these proteins onto the bacterial magnetite surface 
thus control the morphology and size of these nanoparticles (Tanaka, Mazuyama et 
al. 2011).  The authors provided evidence that demonstrated Mms6 may control the 
morphology and size of magnetites in magnetotactic bacteria by regulating the 
surface of crystal during crystal growth.  But the critical question of how does 
Mms6 (or the protein complex that includes Mms6) regulate the surface growth of 
crystals still remains unclear and need further investigation. 
The genomic and proteomic studies of Magnetospirillum magneticum AMB-1 
have identified 48 magnetosome-associated proteins (Matsunaga, Okamura et al. 
2005).  Mms6 is one of these magnetosome membrane-associated proteins 
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consisting of 59 amino acids with a hydrophobic N-terminus and hydrophilic 
C-terminus (Arakaki, Webb et al. 2003).  The hydrophilic C-terminal region of 
Mms6 contain a series of amino acid residues with either hydroxyl or carboxyl 
groups.  The N-terminal domain of Mms6 contains a Leu-Gly-rich region, which is 
similar to some self-aggregating proteins of other biomineralization systems 
(Amemiya, Arakaki et al. 2007; Komeili 2007; Faivre and Schüler 2008; Schüler 
2008).  It has been speculated that the hydroxyl or carboxyl groups in the 
C-terminus of Mms6 may provide a template for magnetic nanoparticle synthesis 
and can control the morphology of the magnetite (Arakaki, Webb et al. 2003).   
Although a lot of effort has been focused on understanding the mechanism of 
magnetosome formation by proteomic and genetic approaches, there are very few 
reports that describe biomineralization mechanism in magnetotactic bacteria or in 
vitro (Faivre, Böttger et al. 2007; Prozorov, Palo et al. 2007; Staniland, Ward et al. 
2007; Tanaka, Mazuyama et al. 2011).  The detailed mechanism of Mms6 promoted 
magnetite nanoparticle formation remains unclear.   
Calcification and Silicification 
In those cases for which there is some understanding of the biological 
mechanisms involved in biomineralization, proteins have been found responsible for 
forming the mineral structures.  But, the mechanisms by which mineralization 
proteins function are poorly understood.  It has been proposed that the mechanism(s) 
involved in biomineralization may include the control of size, morphology, 
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orientation, composition and the location of crystals synthesized by organisms 
(Gower 2008).  The role of proteins in the biomineralization process is critical 
considering that biomineralization occurs readily under mild physiological 
conditions compared with the high temperatures and pressures required to achieve 
the same goals in vitro.   
Unlike the magnetite formation in magnetotactic bacteria, calcification and 
silicification are the two major systems used in nature to fabricate hard skeletal 
tissues and have been under extensive investigation (Bonucci 2009).  We can learn 
from these well studied cases and gain some valuable information in elucidating the 
mechanism of magnetite formation in magnetotactic bacteria.   
Studies of the biomineralization processes that occur in calcification of bone and 
teeth have extended for decades and yet detailed mechanisms to described these 
processes still remains ambiguous (Posner and Betts 1975; Cölfen 2010).  The key 
question of calcification in organism, which is whether the bone mineralized by 
means of ion-based or amorphous precursors, has been debated for decades (Weiner 
2006; Grynpas and Omelon 2007; Olszta, Cheng et al. 2007; Cölfen 2010; Mahamid, 
Aichmayer et al. 2010).  
The main function of collagen in bone mineralization is to act as the protein 
scaffold for the organized arrangement of apatite (Traub, Arad et al. 1989; Hulmes, 
Wess et al. 1995).  Recent in vitro and in vivo studies have provided evidence to 
demonstrate that the function of collagen is as an active scaffold involved in bone 
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mineralization rather than being passive (Dey, Bomans et al. 2010; Mahamid, 
Aichmayer et al. 2010; Nudelman, Pieterse et al. 2010). 
To study the calcium biomineralization process in vitro, Dey et al. used an 
arachidic acid monolayer system to mimic the in vivo biological surfaces that induce 
calcium phosphate biomineralization.  By using cryo-TEM, the investigators 
provided high resolution, time-resolved images of the surface-induced calcium 
phosphate crystallization.  The authors reported existence of small nanometer-sized 
prenucleation clusters in the concentrated calcium solution in which the 
biomineralization of calcium phosphate starts.  These prenucleation clusters then 
aggregate and further coalesce on the surface of monolayer to form amorphous 
spherical small particles.  The development of mature crystals was accomplished by 
the oriented nucleation of amorphous particles directed by the monolayer (Dey, 
Bomans et al. 2010). 
Collagens, the insoluble super macromolecules, are called the structural matrix 
in bone and teeth biomineralization and usually considered as the inactive protein 
scaffold.  A recent study showed the possible active role of collagens in the process 
of apatite biomineralization for bone and tooth formation (Nudelman, Pieterse et al. 
2010).  By using cryo-TEM and molecular modeling of the electrostatic potential 
energy distribution of the collagen fibril, the authors reported that the prenucleation 
clusters are stabilized by polyaspartic acid and form negatively charged loosely 
packed mobile structures.  Modeling of the electrostatic potential energy 
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distribution of the collagen fibrils revealed the existence of positively charged 
regions at the border of gap and the overlap zone.  The authors thus concluded that 
this positively charge region can be used for mineral infiltration and electrostatic 
interaction, which enabled the formation of a dense network of prenucleation 
clusters inside the collagen fibrils.  These prenucleation clusters were then 
transformed into amorphous calcium phosphates and oriented as crystalline 
hydroxyapatite inside the fibrils.  The results showed an active role of collagen for 
the biomineralization of hydroxyapatite, which was to provide the nucleation sites 
for hydroxyapatite crystallization within a charged amino acid domain of the 
collagen fibrils (Cölfen 2010; Nudelman, Pieterse et al. 2010). 
Mahamid et al. used zebrafish as the model system to investigate the bone 
mineralization process in vivo.  By using cryo-SEM imaging and small-angle 
scattering, the investigators validated the hypothesis that the in vivo process of bone 
mineralization starts with the aggregation of prenucleation clusters followed by the 
formation of amorphous apatite calcium phosphates in the collagen fibrils where the 
maturation of crystalline of apatites occurs (Mahamid, Aichmayer et al. 2010). 
The formation of enamel is another well-studied subject in the calcification 
system, which is the outcome of the mineralization of carbonate-apatite with the 
most unusual morphology in biological system.  Mature enamel contains crystals 
that are tens of microns in length with a length to width ratio larger than 1000 
(Daculsi and Kerebel 1978).  The formation of enamel occurs in an extracellular 
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environment and consists of three main stages: secretory, transition and maturation 
(Eastoe 1979; Simmer and Fincham 1995).  As the development of enamel 
continues, the extracellular matrix (ECM) proteins are cleaved by various proteases 
and removed from the mineralization sites in the extracellular matrix, which in turn 
results in the hardness of enamel (Eastoe 1979; Moradian-Oldak 2001). 
Amelogenin, the major component of the extracellular matrix during the 
secretory stage, is believed to be responsible for the formation of the hierarchical 
structure in enamel (Eastoe 1979; Moradian-Oldak 2001).  Amelogin shares many 
similarities with Mms6, the protein of focus for this thesis.  The sequences of 
amelogenins from different species are highly conserved at the carboxyl and amino 
terminal regions. The C-terminus consists of hydrophilic charged amino acid 
residues and the N-terminus is the TRAP (tyrosine rich amelogenin polypeptide) 
region.  The remaining part of amelogenin is the hydrophobic core which is rich in 
proline and leucine residues (Moradian-Oldak, Paine et al. 2000).  The conserved 
TRAP region and the hydrophilic C-terminal region are believed to be the functional 
motifs important for the enamel biomineralization (Simmer and Fincham 1995; 
Fincham, Leung et al. 1998). 
The full length mouse amelogenin has 179 amino acids.  Early research results 
demonstrated that amelogenin can self-assemble into ‘nano-sphere’ structures with a 
hydrodynamic diameters ranging from 15 to 20 nm in vitro (Fincham, 
Moradian-Oldak et al. 1994).  A similar quaternary structure of amelogenin was 
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observed in vivo from high resolution transmission electron microscopy (TEM) 
studies.  The TEM images of the developing enamel from mouse, bovine and 
hamster showed the amelogenin nano-spheres as ‘beaded rows aligned with and 
separating the enamel crystallites’ (Fincham, Moradian-Oldak et al. 1995).  It was 
thus proposed that the nano-sphere structure of amelogenin may function to control 
the crystallite spacing of enamel which is found to be about 20 nm (Fincham, 
Moradian-Oldak et al. 1995; Zeichner-David, Diekwisch et al. 1995).   
The driven force of the self-assembly of amelogenin nano-spheres seems to be 
hydrophobic interactions as it is evident in the primary sequence of amelogenin 
contains a large portion of hydrophobic amino acids.  Proteolysis digestion of 
amelogenin nano-spheres revealed that both the N-terminus and C-terminus of 
amelogenin are exposed (Moradian-Oldak, Jimenez et al. 2001).  Subsequent 
studies further revealed the formation of higher levels of ordered structures which 
were termed as ‘micro-ribbons’ from amelogenin nano-spheres (Du, Falini et al. 
2005).  The authors reported that the amelogenin monomer forms a bipolar globular 
structure with the highly negatively charged C-terminus exposed on the surface of 
molecule.  The oligomerization of amelogenin is driven by inter-molecular 
hydrophobic interactions.  The amelogenin forms dimer, trimer and hexamers. The 
further assembly of the monomeric and multimeric amelogenin molecules results in 
the formation of stable nano-spheres.  These nano-spheres then further 
self-associate and form linear chain structures made of 10 to 15 nano-spheres.  The 
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bipolar nature of amelogenin has been proposed responsible for the re-organization 
of the chain structures to eventually result in formation of the micro-ribbon (Du, 
Falini et al. 2005; Moradian-Oldak, Du et al. 2006).   
The C-terminal segment of amelogenin is highly negatively charged.  Removal 
of the C-terminus results in the formation of more loosely organized and larger 
nano-spheres than formed by the full length amelogenin (Moradian-Oldak, 
Bouropoulos et al. 2002).  A C-terminal deletion mutant of amelogenin failed to 
form micro-ribbon structures (Du, Falini et al. 2005).  More importantly, the 
affinity of C-terminal deletion mutant of amelogenin to apatite crystals was 
significantly lower than that of the full length amelogenin (Moradian-Oldak, 
Bouropoulos et al. 2002).  A solid-state nuclear resonance microscopy (SSNMR) 
study of the LRAP (leucine-rich amelogenin protein, the alternative splicing product 
of the primary amelogenin transcript) revealed that the C-terminal segment of 
amelogenin was oriented to the surface of hydroxyapatite (HAP) so that the acidic 
amino acid residues in the C-terminus can direct interact with the HAP surface direct 
interaction and regulate mineralization (Shaw, Campbell et al. 2004). 
Silicification is another biomineralization process frequently used by organisms 
to fabricate silica-based hard structures such as diatom walls, sponge spicules and 
radiolarian micro skeletons in nature (Crookes-Goodson, Slocik et al. 2008; Bonucci 
2009).  The representative example of silica-based biomineralization process is the 
silicatein directed silicification by sponges.  
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Sponges used high concentrations of silicon in the environment to build spicules, 
which are robust structures of amorphous silica (Crookes-Goodson, Slocik et al. 
2008).  The sponges are constructed with a central proteinaceous axial filament 
surrounded by the annular layers of silica nanoparticles (Weaver and Morse 2003).  
The central proteinaceous axial filaments are composed of three proteins, silicatein α, 
β and γ (Cha, Shimizu et al. 1999; Weaver and Morse 2003).  These three proteins 
form dimers, tetramers and hexamers respectively and undergo phosphorylation 
(Müller, Boreiko et al. 2007). 
The silicatein filaments function in the biomineralization of silicon as both 
templates for silica deposition and dehydrolase for silicon ethoxide condensation 
(Cha, Shimizu et al. 1999; Yan, Katsuhiko et al. 1999).  Silicatein shares high 
sequence homology to cathepsins which are cysteine proteases.  Of the catalytic 
triad of cathepsins, two of amino acid residues, His and Asn, are conserved in 
silicatein.  The mechanism of silicatein-catalyzed polymerization of silica was 
proposed to resemble the catalytic mechanism of a serine protease.  Both the 
dehydration of silicon ethoxide promoted by the silicatein and the cleavage of 
peptides catalyzed by serine proteases must precede through an obligatory hydrolysis 
reaction and both are accelerated by general acid–base catalysis (Cha, Shimizu et al. 
1999; Yan, Katsuhiko et al. 1999; Schübbe, Kube et al. 2003).  Later, this proposed 
catalytic mechanism of silicatein directed silicon formation was confirmed by 
mutagenesis studies (Yan, Katsuhiko et al. 1999).  
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Abstract 
Highly ordered mineralized structures are created by living organisms that are 
often hierarchical in structure with fundamental structural elements at nanometer 
scales.  Proteins have been found responsible for forming many mineral structures, 
but the mechanisms by which biomineralization proteins function are generally 
poorly understood.  We discuss studies of the magnetotactic bacterial protein, 
Mms6, which promotes the formation in vitro of superparamagnetic magnetite nano-
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crystals.  Mms6 has two phases of iron binding, one high affinity (Kd=10-16 M) and 
stoichiometric and the other low affinity (Kd =5.5 ± 4.0 µM), high capacity, cooperative 
with respect to iron and temperature sensitive.  Iron binding initiates a very slow 
structural change in the protein.  We propose a model for the mechanism of action 
of Mms6 in which a conformational change driven by iron bound to the C-terminal 
domain initiates a coordinated structural change involving multiple proteins to form 
a surface that can accumulate a cluster of iron atoms, which might then be organized 
into seed crystals.  
Introduction 
Magnetotactic bacteria are aquatic prokaryotes that can move under the direction 
of local geomagnetic field lines (1).  All magnetotactic bacteria have unique 
intracellular structures called magnetosomes that consist of magnetic nanoparticles 
surrounded by lipid bilayer membranes (2-4).  The composition, size and 
morphology of magnetites synthesized by magnetotactic bacteria are 
genetically-defined (5,6).  Magnetotaxis is proposed to simplify the bacterial search 
for the optimal oxygen environment to a one-dimensional rather than a random three 
dimensional path (1,5,7,8).  
The formation of magnetosomes in bacteria involves membrane invaginations to 
form vesicles in which iron accumulates and magnetite nanoparticles grow by a 
controlled mechanism (5).  Recent genomic and proteomic studies of 
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Magnetospirillum magneticum strain AMB-1 have identified 48 
magnetosome-associated proteins (9).  One of these, Mms6, is a magnetosome 
membrane-associated protein, the mature form consisting of 59 amino acids (10).  
Magnetite nanoparticles with similar size and shape to the wild-type bacterial 
magnetite crystals are formed in vitro in the presence of recombinant Mms6 alone 
(10,11).  Deletion of the Mms6 gene from the bacterial genome results in a change 
in crystal structure of the magnetites formed by these mutant bacteria and a decrease 
in the number of magnetosome proteins associated with the magnetite nanoparticles 
(12).  Although these results show that Mms6 is not required to promote the 
formation of iron particles in magnetotactic bacteria, it has not yet been determined 
if the particles produced by the mutant bacteria have the same magnetic 
characteristics as the wild-type particles.  Thus, it is unclear if Mms6 is required to 
form magnetic nanoparticles in this strain of magnetotactic bacteria.  As well, it is 
well known that many biological systems that are critical for the organism to survive 
contain redundancy in the protein required activities.  Thus, it remains to be seen to 
what extent Mms6 is unique in its ability to form magnetic particles in magnetotactic 
bacteria.  However, its ability to do so in vitro provides us an opportunity of 
understanding the mechanism by which this protein can promote the formation of 
magnetic nanoparticles.  
Here, we observed that Mms6 forms a micellar quaternary structure in vitro that 
may provide a surface for magnetite nanoparticle formation.  Mms6 consists of two 
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subdomains, with the N-terminal domain responsible for anchoring the C-terminal 
domain in a micelle from which the C-terminal domain interacts with iron to form 
magnetic nanoparticles.  Analysis of Mms6 and its C-terminal domain by 
fluorescence, and NMR spectroscopy provides evidences that the protein undergoes 
a slow structural change upon binding iron and that the protein interacts with iron in 
two ways, the first stoichiometric and high affinity (Kd=10-16 M) and the second low 
affinity (Kd =5.5 ± 4.0 µM), high capacity (~20 Fe3+/Mms6) and cooperative with 
respect to iron.  We propose that the structural basis of formation of magnetic 
particles by Mms6 is the C-terminal-driven formation of a platform of iron-binding 
C-terminal domains on the membrane of the magnetosome or on a micellar surface 
that concentrate iron and nucleate the formation of crystal seeds.  
Experimental Procedures 
Materials- The mature form of Mms6 was expressed with a poly-histidine tag 
extending from the N-terminus with an enterokinase cleavage site located between 
the tag and Mms6 (referred to here as His-Mms6) and purified as described 
previously (11).  The C-terminal domain of Mms6 (C21Mms6: KSRDIESAQSDEE
VELRDALA) was synthesized by Genscript (Genscript Corp., www. genscript.com), 
provided as a solution in water, and used as received.  The concentration of 
C21Mms6 was determined fluorescently by OPA with C25Mms6 
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(YAYMKSRDIESAQSDEEVELRDALA) as standard (The concentration of 
C25Mms6 was determined by A280 using extinction coefficient of 2980 M-1 cm-1).   
His-Mms6 mutants- Expression vectors for His-m2Mms6 and His-m3Mms6 were 
prepared using annealed complementary oligonucleotides encoding the appropriate 
mutant sequence to replace the previously cloned wild-type sequence (11).  The 
proteins were expressed and purified as for His-Mms6 (11).  The sequences of the 
21 C-terminal part of His-m2Mms6 and His-m3Mms6 are KDRSIDEAQESDSVEL
REALA and QSLERAEDEDADISAVEKLSR respectively compared with the 
sequence of the His-Mms6 C-terminal domain (KSRDIESAQSDEEVELRDALA).  
For the m2 mutant the instances of amino acid replacement are bolded and also 
underlined when a -OH and -COOH side chain have been interchanged.  The 
sequences of all other parts of these three proteins are the same.  CLC protein 
workbench software (CLC bio) was used to identify the sequences for His-m2Mms6 
and His-m3Mms6 that possessed similar hydropathy plots to that of Mms6.  
Analytical ultracentrifugation- One half mL of 0.46 mg/mL (A280=0.702) 
His-Mms6 in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,1.4 mM KH2PO4, pH 
7.2 was loaded into the cell and placed in an AN60 rotor in a Beckman Proteome 
Lab XL-A Protein Characterization System (Beckman) for centrifugation.  The 
time-dependent sedimentation of His-Mms6 was monitored at 280 nm, 65,520 x g, 4
℃?  for 2 h.  The profile of sedimentation coefficient of His-Mms6 was generated 
by the method of van Holde and Weichet using Ultrascan 8.0 for Windows system 
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(13-15).  The v-bar (0.72) calculated by Ultrascan 8.0 from a weight average of the 
partial specific volumes of the component amino acid residues of His-Mms6 were 
used in the analysis.  The apparent molecular mass was estimated by the calculator 
provided in Ultrascan 8.0 using the sedimentation coefficients observed assuming 
His-Mms6 protein is globular. 
Size exclusion chromatography- Chromatography was performed in an AKTA 
FPLC system (GE healthcare) through prepacked Superose 12 10/300GL (separation 
range: 1 kDa to 300 kDa) and Superdex Peptide 10/300GL (separation range: 700 Da 
to 20 kDa) columns at 4 ℃? .  Flow rates were 0.4-0.5 mL/min. All column samples 
were prepared by centrifugation at 14,000 g at 4 ℃?  for 1 h before loading onto the 
columns.  Blue dextran was used to determine the void column volume (Vo) of each 
column.  The elution volumes (Ve) of cytochrome c (MM 10.37 kDa, aprotinin 
(MM 6.5 kDa), insulin B chain oxidized form (MM 3495 Da) and B12 (MM 1355 
Da) (all from Sigma) from a Superdex Peptide 10/300GL column were used to 
generate the standard curve for the apparent molecular mass estimations of 
C21Mms6.  The C21Mms6 was identified using o-phtalaldehyde (16) (OPA, 
Thermo Scientific) by adding 200 µL of OPA to 20 µL of column fraction and 
measuring fluorescence (Ex: 350 nm, Em: 450 nm). 
Liposome preparation- 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) in chloroform at a molar 
ratio of 85:15, were dried by vacuum and resuspended in 20 mM Tris-HCl, 100 mM 
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KCl, pH 7.5.  Liposomes were prepared by extrusion through polycarbonate filters 
(all reagents from Avanti Polar Lipids) (17).  
Proteolytic digestion- Two conditions were used for proteolytic digestion of 
His-Mms6.  In the first case, 1 mg/mL His-Mms6 was digested with 0.1 mg/mL 
proteinase K (Sigma) in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 and incubated at 
25℃?  for up to 24 h.  In the second case, 1 mg/mL His-Mms6 was first incubated 
with 10 mM (total lipid concentration) liposome in 20 mM Tris-HCl, 100 mM KCl, 
pH 7.5 with and without 0.5 % Triton X-100 and incubated at 25 ℃?  or 4 ℃?  for 1 h 
with constant mixing by inversion.  Samples that included 0.5 % Triton X-100 were 
then dialyzed against 20 mM Tris-HCl, 100 mM KCl, pH 7.5 with three changes in 
the presence of Bio-Beads SM-2 detergent adsorbent beads (Bio-Rad) to remove the 
Triton X-100 (17).  His-Mms6 (0.8 mg/mL) with liposomes was digested with 0.2 
mg/mL proteinase K in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 at 25℃?  for up to 24 
h.  All reactions were stopped with 9 mM phenylmethylsulfonyl fluoride (Sigma) 
then 95 ℃?  for 5 min.  The samples were then resolved by polyacrylamide gel 
electrophoresis (PAGE) through a 15 % gel in the presence of 0.1 % SDS. 
Fluorescence spectroscopy- The tryptophan fluorescence of His-Mms6 was 
measured in either 96-well plates or in a quartz cuvette at 25 ℃?  with a fluorescence 
spectrophotometer (Varian, Model: Cary Eclipse), at excitation and emission 
wavelengths of 290 nm and 345 nm respectively.  The quenching of His-Mms6 
tryptophan fluorescence in the presence of different concentrations of ferric citrate 
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was used to calculate the fraction of binding sites occupied, B: B= (Fb-F)/(Fb-Ff) 
where F is the fluorescence signal at a given concentration of iron and Fb and Ff are 
the signals when the binding sites are fully unoccupied and occupied respectively.(18)  
In this assay, His-Mms6 (5 µM) was incubated with ferric-citrate (Sigma) at 
concentrations ranging from 0 to 100 µM in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 
in separate brown test tubes for 2 h at 25 ℃?  before the fluorescence measurements 
were taken.  
For the studies of the time dependent fluorescence change of His-Mms6 upon 
free ferric ion addition, 5 µM His-Mms6 or His-m2Mms6 in 50 mM sodium formate, 
100 mM KCl, pH 3 were mixed with or without FeCl3 at molar ratios of 
protein:FeCl3 from 1:2 to 1:6 (inclusive of all unit values) and monitored every 15 
min (Ex: 290 nm, Em: 340 nm) at 25 ℃?  with a fluorescence spectrophotometer 
(Varian, Cary Eclipse).  
55Fe3+ binding assays- In measuring the affinity of His-Mms6 for iron by the filter 
assay (19), the concentration of His-Mms6 was 100 nM or 1 µM throughout.  The 
solution contained 100 mM KCl and the pH was either pH 3 (adjusted with HCl) or 
pH 7.5 for all studies with ferric-citrate (established with 20 mM Tris-HCl).  Under 
these conditions, His-Mms6 was incubated with 55Fe (PerkinElmer) in the form of 
ferric chloride or ferric citrate at various concentrations of iron as indicated for 
individual experiments in the legends to figures.  Unless otherwise noted, the 
incubations were two hours at 4 ℃?  or 25 ℃? .  The incubations with ferric citrate 
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were done in brown test tubes to prevent possible auto-reduction of ferric citrate (20).  
The incubated samples were filtered through 0.45 µm nitrocellulose membranes 
(Millipore) that had been prewashed with the same buffer solution and at the same 
temperature as during the incubation.  The membranes were washed with two 
consecutive 5 mL volumes of buffer at the same temperature as during the incubation 
then removed and the captured radioactivity was counted using Scintiverse BD LSC 
Cocktail scintillation solution (Fisher Scientific) and liquid scintillation analyzer 
(Packard model 1600 TR).  The highest background observed with this method was 
less than 1% of the maximum bound values.  The retention efficiency of His-Mms6 
hold by the filter with this method was about 90% (Supplementary Table 1) 
Scatchard plots were used to calculate the Kd of His-Mms6 for iron in all 
binding assays (21).  The equation used is: B/F=Bmax/Kd-B/Kd, where B is the 
amount of iron bound by His-Mms6, F is the free, unbound iron concentration in 
solution and Bmax is the maximum amount of iron bound by His-Mms6.  By 
plotting B/F versus B, the Bmax and Kd can be calculated from the Y and X-axis 
intercepts. The stoichiometry between iron and protein was then determined by 
Bmax/protein (molar ratio).  The absolute Kd of His-Mms6 for ferric iron at pH 7.5 
was calculated by the equation Kd=Kdapp x Kd (ferric-citrate), where Kdapp is the binding 
constant of His-Mms6 for iron observed at pH 7.5, Kd (ferric-citrate) is the dissociate 
constant of ferric citrate at pH 7.5. 
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Nuclear magnetic resonance (NMR) spectroscopy- NMR analysis was performed 
on a Bruker AVII700 equipped with a 5 mm TCI cryoprobe.  All NMR analyses 
were performed at 25 ℃? . Each 1H1D spectra was acquired using pre-saturation for 
solvent suppression (Bruker pulse program zgpr) and consisted of 64 scans with an 
acquisition time of 3 min.  2D 1H-1H TOCSY and NOESY spectra were collected 
using standard experimental protocols (Bruker pulse programs mlevgpgp19 and 
noesygpph19, respectively) with WATERGATE solvent suppression. The TOCSY 
experiment consisted of 256 time increments of 8 scans each, with a total acquisition 
time of 43 min and MLEV17 mixing time of 80 ms.  The NOESY experiment 
consisted of 512 time increments of 64 scans each, with a total acquisition time of 
7.5h and NOESY mixing time of 400 ms. All NMR data were processed and 
analyzed using Bruker Topspin 2.1 software.  
Dynamic Light Scattering (DLS)- His-Mms6 (0.5 mg/ml) in 100 µL of 137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2 at 25 ℃?  were 
analyzed with a Zetasizer Nanoparticle analyzer (Model: ZEN3690, Malvern 
Instrument Ltd.).  Each measurement consisted of 11 acquisitions of 10s with 3 
repeats. Data were processed by using Dispersion Technology Software 5.00 
(Malvern Instrument Ltd).  The buffer was filtered through a 0.45 µm nitrocellulose 
membrane and the protein samples were centrifuged for 1h (14000 g, 4 ℃? ) prior to 
use.  
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Results  
High affinity iron binding by Mms6.  The affinity of Mms6 for iron has so far only 
been shown qualitatively (10,11).  We determined the binding constant and 
stoichiometry of iron to Mms6 using 55Fe and ferric citrate (55FeCl3:citric acid = 1:1 
(M/M)) to accurately provide adequately low concentrations of 55Fe3+ to assess high 
affinity binding at pH 7.5.  A Scatchard plot of the results yielded a Kdapp of 30 µM 
for ferric citrate bound to His-Mms6 protein with a 1:1 stoichiometry (Fig. 1A.●).  
After taking into consideration the Kd (10-11.5 M) of ferric citrate for Fe3+ (22,23) the 
Kd of His-Mms6 for iron was calculated to be 10-16 M.  
The amino acid side chains that could chelate iron are located in the C-terminal 
domain.  To examine if the C-terminal sequence of Mms6 is responsible for this 
high affinity iron binding, we tested two mutant forms of His-Mms6.  The first 
mutant (His-m2Mms6) had the same sequence as His-Mms6 through to the final 21 
amino acids, in which the residues containing –OH and –COOH groups, that are 
expected to be involved in chelating the Fe3+, were shuffled.  The second mutant 
(His-m3Mms6) also had the same sequence as His-Mms6 up to the last 21 amino 
acid residues, which were scrambled. Neither His-m2Mms6 nor His-m3Mms6 
showed high affinity binding of Fe3+ (Fig. 1A, □, ). The estimated Kd of 
His-m2Mms6 was 52 µM (The number of Fe3+ bound per His-m2Mms6 at saturation 
was 0.2). The estimated Kd of His-m3Mms6 was 9.8 µM (The number of Fe3+ bound 
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per His-m2Mms6 at saturation was 0.1). The fitting of the scatchard plot was poor in 
both case (R2=0.54 and 0.66 respectively). 
The C-terminal segment of Mms6 alone was also tested for iron binding.  The 
initial trial of test of the C-terminal for iron binding by filter assay was not 
successful because the C-terminal peptide (C21Mms6) is not sufficiently 
hydrophobic to be adsorbed by the nitrocellulose membrane filters and too small to 
be retained by the 0.45 µm diameter pores of the filters.  The iron binding activity 
of C21Mms6 was qualitatively examined by size exclusion chromatography at 
pH7.5 using ferric citrate (Fig. 1B).  The C21Mms6-bound and unbound Fe3+ were 
separated by size exclusion chromatography (Fig. 1B).  The Fe3+-bound C21Mms6 
fraction was quantified fluorescently by OPA with C25Mms6 (YAYMKSRDIESA
QSDEEVELRDALA) as standard (its concentration was determined by A280 using 
extinction coefficient of 2980 M-1 cm-1).  Using the ferrozine assay to determine the 
concentration of iron bound by C21Mms6, the binding of Fe3+ by C21Mms6 was 
found to be stoichiometric.  Although this method does not provide an affinity 
constant of the C-terminal segment of Mms6 for Fe3+, the fact that C21Mms6 binds 
Fe3+ stoichiometrically in the presence of excess citrate indicates that it has a higher 
affinity than citrate for Fe3+, which is 10-11.5 M  These results, combined with 
previous observations that the C-terminal segment of Mms6 can promote the 
formation of magnetic particles (24,25), identifies the C-terminal domain of Mms6 
as responsible for high affinity stoichiometric iron binding.  
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Two distinct phases of iron binding by Mms6.  Due to the necessity of maintaining 
equilibration between Fe3+ and citrate, the previously described studies were 
performed at pH 7.5 at which pH the affinity of citrate for Fe3+ is high (10-11.5 M).  
However, nanoparticle formation by His-Mms6 in vitro is achieved at high iron 
concentrations (mM) that cannot be achieved at neutral pH due to the insolubility of 
hydrated Fe3+ for which the equilibrium concentration cannot exceed 10−17 M at pH 
7 (26).  Therefore, the concentration dependence of Fe3+ binding to His-Mms6 was 
also determined at pH 3 (Fig. 2).  Again evidence of stoichiometric, high affinity 
Fe3+ binding was observed (Fig. 2,●).  However, with increasing concentrations of 
iron, a second phase of iron binding to His-Mms6 was discovered with an apparent 
low affinity and a stoichiometry much higher than 1:1 (Fig. 2,●).  Scatchard plots 
revealed two phase of binding (Fig. 2 lower right Inset).  The first high affinity 
phase revealed stoichiometric (Fe3+:His-Mms6=1:1).  Although a high apparent 
affinity (Kdapp = 0.44 ± 0.06 µM) was measured, this value cannot be accurately 
determined in this context due to the high ratio of protein to Fe3+.  The second 
binding phase has a much lower apparent affinity (Kdapp = 5.5 ± 4.0 µM) of iron with 
His-Mms6 and a stoichiometry of about 19:1 (19 ± 8).  To test whether the high 
stoichiometry binding of iron for His-Mms6 was due to iron precipitation, 
His-m2Mms6 (shuffled C-terminal –OH and –COOH groups) and His-m3Mms6 
(scrambled C-terminal amino acid sequence) were incubated with iron under the 
same conditions as for His-Mms6 (Fig. 2, , ◊).  Neither showed evidence of either 
55 
phase of iron binding observed with His-Mms6.  A Hill plot revealed cooperativity 
of the second binding phase of Fe3+ binding to His-Mms6 (Hill n value ~3, Fig. 2 
upper left Inset).  As a control for nonspecific binding, His-m2Mms6 (shuffled 
C-terminal –OH and –COOH groups) and His-m3Mms6 (scrambled C-terminal 
amino acid sequence) were incubated with iron under the same conditions as for 
His-Mms6 (Fig. 2, , ◊).  Nonspecific iron binding did not become apparent until 
the iron concentration was about 3 µM (Fig. 2, ◊).  
The low affinity high capacity binding of iron by Mms6 cannot be readily 
explained by the number of potential chelating residues in the C-terminal domain 
this protein (7 -COOH and 3 -OH), particularly as the first high affinity binding 
likely involves more that one of these residues.  To resolve this inconsistency, we 
postulated that the initial stoichiometric binding of iron might result in a structural 
change in Mms6 to promote their interactions to form a larger complex that 
promotes iron clustering.  This explanation is also consistent with the observed 
cooperativity of Fe3+ binding with respect to iron concentration.  Based on results 
reported in the next section that are consistent with Mms6 forming a micellar 
quaternary structure, we also speculated that the structural change might involve the 
N-terminal segment in strong hydrophobic and van der waals interactions and might 
be prevented or slow down at lower temperatures.  Therefore, we determined the 
binding curve of His-Mms6 as a function of Fe3+ concentration at 4℃?  with and 
without incubation for 2h at 4℃?  before capturing on the filters.  Under these 
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conditions, His-Mms6 only demonstrated high affinity stoichiometric binding (Kdapp 
= 1.1 ± 0. 3 µM, Fig. 2, Ο, ) and no high capacity binding was observed.  
His-Mms6 exists in aqueous solution as large micelles.  The high capacity iron 
binding and almost equal length of the hydrophobic N-terminal domain and hydro-
philic C-terminal domain suggested that Mms6 might form micelles or larger 
quaternary structures.  To investigate this hypothesis, the apparent molecular mass 
of His-Mms6 was investigated by size exclusion chromatography (Fig. 3A), 
analytical ultracentrifugation (Fig. 3B) and DLS (Fig. 3C).  These studies showed 
that His-Mms6 exists in large complexes.  The monomeric molecular mass of 
His-Mms6 is 10.2 kDa. But, the peak of His-Mms6 eluted through a Superose 12 
column (separation range: 1 kDa to 300 kDa) in the void volume as identified by 
blue dextran, which suggests an apparent molecular mass equal of or greater than 
300 kDa (Fig. 3A).  Assuming that His-Mms6 is a globular protein, we expected a 
sedimentation coefficient of 1.16S for monomeric His-Mms6.  The observed 
sedimentation coefficients, distributed from 20 to 100S with the majority between 20 
and 40S, also indicate that His-Mms6 forms large multimers with an estimated 
apparent molecular mass between 200 kDa and 400 kDa (Fig. 3B and 
Supplementary Fig. 4).  Dynamic light scattering showed two particles sizes 
between which the protein mass is almost equally distributed (Fig. 3C). Peak 1 was 
59% of the mass and particles with a mean radius of 5.1 ± 1.5 nm and an estimated 
molecular mass of ~200 kDa (Fig. 3C).  Peak 2 contained 41% of the protein mass 
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and particles with a mean radius of 12 ± 6.5 nm and an estimated molecular mass of 
~2000 kDa (Fig. 3C).  Although these latter particles contained a significant portion 
of the mass, they only represent 6% of all particles.  Thus, the results of size 
exclusion chromatography, analytical ultracentrifugation and DLS studies show that 
His-Mms6 forms large multimers with most of the particles containing 20-40 protein 
molecules.  
To test the hypothesis that the quaternary structure of His-Mms6 is a micelle 
with the N-terminal domain inside and the C-terminal domain outside, we first 
examined if the C-terminal domain is external and accessible for proteolytic 
cleavage (Fig. 3D).  Digestion of His-Mms6 with proteinase K resulted in a 
significant decrease in its monomeric size within 5 min (Fig. 3D, middle panel).  
This rate of loss of His-Mms6 molecular mass was similar to the rate of degradation 
of C21Mms6 incubated under the same conditions (Fig. 3D, bottom panel).  A 
protease-resistant fragment of His-Mms6 remained even after 24 h digestion (Fig. 
3D, middle panel) whereas, like C21Mms6, BSA was digested almost completely by 
this time (Fig. 3D, top panel).  The proteinase K-resistant portion of His-Mms6 was 
not soluble in aqueous buffer (no detergent was present in the buffer) and was found 
as a precipitate, which is consistent with the presence of a hydrophobic resistant core.  
N-terminal sequencing results also confirmed that the precipitate consisted mainly of 
hydrophobic and aromatic amino acids (Supplementary Table 2).  At higher 
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concentrations of proteinase K the N-terminal domain was also degraded (Fig. 3E, 
last lane) 
 Although it has some characteristics of a membrane protein, His-Mms6 does not 
require detergent for its solubility in aqueous solution.  If it forms a micellar 
quaternary structure, these micelles should also fuse directly with liposomes without 
the aid of a detergent.  His-Mms6 was mixed with liposomes in the presence or 
absence of Triton X-100 and at either 4℃?  or 25 ℃?  (Fig. 3E).  To determine if the 
protein had been incorporated into the liposomes, the mixture was incubated with a 
high concentration of proteinase K (His-Mms6 : proteinase K=4 : 1) that completely 
degraded His-Mms6 alone (Fig. 3E, last lane).  A proteinase K-resistant fragment 
was observed when His-Mms6 was incubated with liposomes in the presence or 
absence of Triton X-100 (Fig. 3E, lanes 2 and 4).  This proteinase K resistant 
fragment is larger than that produced when Mms6 is incubated with proteinase K in 
the absence of liposome at higher His-Mms6/proteinase K ratio (10:1) (Fig. 3E, 
lanes 5), which is consistent with the expectation that, when buried in the liposome, 
more of the Mms6 N-terminal domain might be protected from proteolysis than in 
the absence of liposome membrane such as in Fig. 3D and Fig. 3E, lane 5.  Thus, as 
expected of a micelle, detergent is not required for His-Mms6 to incorporate into 
liposomes.  The inclusion of Triton X-100 during membrane insertion also resulted 
in a portion of full-length His-Mms6 being completely proteinase resistant (Fig. 3E, 
lanes 2).  This could be due to the inclusion of some of the His-Mms6 either inside 
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the liposomes or incorporated into the membrane with the C-terminus in the 
liposome lumen rather than on the outside where it is susceptible to the proteolytic 
action of proteinase K.  Decreasing the incubation temperature below the liquid to 
solid phase transition temperature of the liposomes resulted in less protection of 
His-Mms6 from proteinase K (Fig. 3E, lane 3), which is also consistent with the 
protein incorporating into the liposomes in the absence of detergent.  In the absence 
of liposomes, a low ratio (4:1) of His-Mms6 to proteinase K resulted in complete 
degradation of His-Mms6, which did not occur at the higher His-Mms6/proteinase K 
ratio used for the remaining conditions in experiment described in Figure 3D and E.  
In summary, we have found that His-Mms6 1) exists in large particles in 
aqueous solution and in the absence of detergent and its 2) C-terminal domain can 
readily be cleaved leaving a protease-resistant core, 3) can fuse in a temper-
ature-dependent manner with liposomes, and 4) form monolayer on an aqueous 
surface in a Langmuir trough (Supplementary Fig 1).  In their entirety, these results 
provide strong evidence that His-Mms6 forms a micellar quaternary structure.  
The C-terminal domain of Mms6 adopts a defined conformation. Many short 
peptides are inherently disordered. But, the Mms6 C-terminal domain alone can 
direct the formation of magnetic nanoparticles in vitro when linked to polymer (21).   
If the mechanism of nanoparticles formation by Mms6 involves the C-terminal 
domain binding iron at high stoichiometry then C21Mms6 might be capable of 
forming a defined structure.  We used 2D 1H-1H TOCSY and NOESY spectra to 
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investigate the structure of C21Mms6 (Fig. 4A).  The TOCSY (total correlation 
spectroscopy) transfers magnetization through the chemical bonds between adjacent 
protons within the same spin system. The NOESY (total correlation spectroscopy) 
transfers magnetization between protons that are close in space (< 5Å) and the 
intensity of the cross peaks are proportional to 1/r-6.  So, by overlay the TOCSY and 
NOESY spectra, we can identified those protons which are not in the same spin 
system while spatially close which can be used as an indication of the existence of a 
structured molecule. We found that the NOESY spectrum of C21Mms6 included 
numerous non-sequential, inter-residue amide to side-chain NOE cross peaks and, 
most notably, six amide to amide cross peaks.  These cross peaks indicate that 
C21Mms6 has a stable conformation in solution (Fig. 4A).  The detailed 
assignments of the NMR spectra and the modeling of the structure of C21Mms6 are 
ongoing 
To determine if interactions between C-termini might contribute to the micellar 
structure, we also investigated the hypothesis that C21Mms6 forms multimers.  The 
monomeric form of C21Mms6 has a molecular mass of 2.36 kDa.  The apparent 
molecular mass of C21Mms6 in 100mM KCl at pH7.5 and pH3 was estimated to be 
4.6 and 5.3 kDa respectively (Fig. 4B).  The results of analysis by size exclusion 
chromatography showed that C21Mms6 exhibited dimeric apparent molecular mass 
in 100 mM KCl at both pH 7.5 and pH 3 (Fig. 4B).  In the presence of 6M 
guanidinium HCl, C21Mms6 runs as a monomer (Supplement Fig. 2). 
61 
Mms6 conformation changes on iron binding. The biphasic iron binding of 
His-Mms6 combined with its multimeric quaternary structure suggested that the 
protein itself might change in conformation on binding iron.  To examine the effect 
of iron on His-Mms6 structure, we took advantage of the presence of two trp 
residues in the N-terminal domain (W5 and W21), and looked for an effect of iron 
binding on trp fluorescence.  His-Mms6 was incubated with a range of 
concentrations of ferric-citrate at pH7.5 for 2h and the fluorescence was monitored 
(Fig. 5A).  From this study the Kdapp of His-Mms6 was determined to be 22 ± 8.6 
µM by Scatchard plot (Fig. 5 B) and thus the Kd to be 6 x 10-17 M, which matches 
well the Kd determined using the 55Fe filter binding assay (Fig. 1A).  Similar 
fluorescence quenching was not observed for His-m3Mms6 (Supplementary Fig.5) 
which did not bind ferric citrate when measured with filter binding assay (Fig. 1).  
This result indicates that the fluorescence quenching was resulted from the binding 
of ferric iron at the C-terminal domain of Mms6 protein. 
Mms6 undergoes a slow structural change after the addition of iron.  The change 
in Mms6 structure, as reflected by the trp fluorescence quenching, was surprisingly 
slow and occurred over a period of hours (Fig. 5C, ).  The slow kinetics is also 
supported by a similarly timed change in line broadening in the 1H-NMR proton 
spectra, which again sharpen after 4 h and before 24 h (Fig. 5D).  A similar change 
in fluorescence quenching was not observed with His-m2Mms6 (Fig. 5C, ). 
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Discussion 
To understand how a protein, such as Mms6, promotes the alignment of iron 
atoms to form a crystal, it is important to know the structure of this protein and how 
it might respond to the presence of iron.  With Mms6 being a very small protein (59 
amino acids), it seemed likely that the relevant functional form of this protein 
involves a larger multimeric assembly.  The N-terminal domain of Mms6 contains a 
Leu-Gly rich region, which is similar to some self-aggregating proteins of other bio-
mineralization systems (7,27-29), and is consistent with the possibility that 
His-Mms6 similarly forms a larger structure.  We examined the quaternary structure 
of His-Mms6 and found that the N-terminal domain self-assembles into relatively 
uniform micelles of 20-40 units with the C-terminal domain on the surface.  
Although, it would be desirable to solve the structure of full length Mms6 by X-ray 
cryptography or NMR spectroscopy, we have not yet been able to obtain a 
homogenous Mms6 monomer.  No homogenous monomeric form of His-Mms6 
was obtained in either 4 M urea or 6 M GnCl (Supplementary Fig 6).  Therefore, 
we have used other biophysical and biochemical analyses to understand the structure 
of this unusual protein such as fluorescence spectroscopy, size exclusion 
chromatography, dynamic light scattering, analytical ultracentrifugation, and filter 
binding assay. 
When linked to Pluronic® F127, a block copolymer, both C21- and C25Mms6 
are able to promote magnetite nanoparticle formation in vitro similarly to the full 
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length protein (unpublished and 25).  Here we show that C21Mms6 binds Fe3+ 
tightly and that His-Mms6 binds one Fe3+ with a very high affinity (Kd = 10-16 M) 
that is close to the affinity of transferrin for Fe3+ (Kd = 10-18 M) (30).  However, 
10-16 M is well below the concentration of iron expected to be present in the 
magnetosome during crystal formation and is also well below the mM concentration 
of Fe3+/Fe2+ present during in vitro synthesis.  To achieve these higher iron 
concentrations we measured His-Mms6 binding to iron at pH 3 and observed two 
binding phases with respect to iron concentration: a high affinity phase (Kdapp = 0.44 
± 0.06 µM) and a second low affinity phase (Kdapp = 5.5 ± 4.0 µM).  Both 
iron-binding phases are likely to be relevant to iron crystal formation.  We 
speculate that the first high affinity phase alters the C-terminal conformation, which 
results in a structural change in a multimeric protein complex that enables the second 
low affinity iron binding phase in which iron clusters on the protein cooperatively 
and at high stoichiometry.  
In these studies, we have used a recombinant form of Mms6 that includes a 
histidine tag (His-Mms6).  Although it would be desirable to obtain the protein 
without the histidine tag, we have not yet found a reliable means of achieving this 
goal.  The optimization of the enzymatic cleavage conditions (incubation time, 
metal ion) used to remove the His-tag of His-Mms6 by enterokinase resulted in the 
nonspecific cleavage at the C-terminus of Mms6 with the His-tag uncleaved (31).  
The inclusion of detergents or urea also did not promote cleavage of the His-tag 
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(Supplementary Fig.7).  His-Mms6 has the same activity as originally described for 
Mms6 (10) in that it promotes the formation of magnetic magnetite nanoparticles of 
a size and shape similar to the biologically formed crystals in magnetosomes as we 
previous characterized using magnetic property measurement, TEM and powder 
X-ray diffraction analysis (11).  The mutant proteins, His-m2Mms6 and 
His-m3Mms6, were controls for actions, if any, of the His tag.  In addition, studies 
with the C-terminal peptide (C21Mms6), which has no His tag, confirmed or 
supplemented results obtained with the full-length protein.  
The low affinity iron-binding activity of His-Mms6 is cooperative with respect 
to iron concentration (Hill n value ~3) and involves a massively high stoichiometry 
of iron/His-Mms6 (~19/1).  The observed cooperativity suggests that the protein is 
organizing the iron on its surface in such a way that the presence of some iron atoms 
on the surface promotes the incorporation of other iron atoms.  This might reflect 
the beginning of crystal packing.  The high stoichiometry of iron/His-Mms6 that is 
achieved in the low affinity phase of iron binding is difficult to explain based on the 
number of potential chelating residues in the His-Mms6 sequence.  
The results reported here provide the basis for a model of a mechanism by which 
Mms6 promotes iron crystallization in vitro (Fig. 6).  In this model, it is proposed 
that the high affinity and stoichiometric binding of iron by the C-terminal domain of 
Mms6 changes the monomer structure causing a change in quaternary structure of 
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the micellar protein complex that allows the cooperative binding of iron at high 
stoichiometry.  In vivo a similar mechanism might operate on the membrane. 
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Figure Legends 
Fig. 1. Iron binding characteristics of Mms6.  A) Single high affinity binding site 
of Mms6 for iron. 55Ferric citrate, over the concentration range of 1 to 50 µM was 
incubated with 1 µM His-Mms6 in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 in brown 
test tube for 2 h, followed by capture of the bound iron by the filter assay.  All data 
points are the average of duplicate values.  The inset shows the Scatchard plot used 
to calculate the Kd of ferric ion binding to His-Mms6. His-Mms6 (), His-m2Mms6 
(□), His-m3Mms6 ().  In the Scatchard plot, B/F is the amount of iron bound by 
His-Mms6 (B) versus free unbound iron concentration (F).  B) Iron is bound by the 
C-terminal domain of Mms6. The elution profile is shown of C21Mms6 with 
Fe3+-citrate from a Superdex peptide 10/300GL (separation range 700 Da-20 kDa) 
gel filtration column run at 0.4mL/min ().  Fe3+-citrate was also run through the 
column in the absence of peptide at 0.4 mL/min ().  The total iron content of each 
fraction was determined by the ferrozine assay (A562).  The molar ratio of iron to 
C21Mms6 at saturation was determined to be 1.  The elution profile of C21Mms6 
was established by PAGE of each sample and confirmed to coincide with the elution 
profile of the identified Fe3+-bound-C21Mms6.  Arrow indicates the void volume 
of the column 
 
Fig. 2. Two phases of iron binding by Mms6.  Binding of His-Mms6 to free ferric 
ion was measured using 55FeCl3 with the filter assay at pH 3.  The reaction mixtures 
69 
contained 100 nM His-Mms6 (,, Ο), His-m2Mms6 (◊), or His-m3Mms6 () in 
20mM Tris-HCl, 100mM KCl, pH 3.  Incubation was for 2 h at 25 ℃?  (,◊,) or at 
4 ℃?  (Ο) or no preincubation at 4 ℃?  () followed by collection and analysis by the 
filter assay.  All data are the average of duplicate values. Error bars represent the 
standard deviations.  Inset (Upper left): Hill plot of the second phase of iron 
binding by Mms6.  θ=Y/(1-Y), where Y is the fraction of the occupied sites bound 
by iron.  Y was defined by the equation: Y=[Fe]n/(Kd+[Fe]n), n: Hill coefficient, 
[L]:free iron concentration, Kd: dissociate constant of His-Mms6 for free ferric iron. 
Because log(θ)=n*log[Fe]-logKd, the Hill coefficient can be obtained by plotting log 
(θ) versus log [Fe].  Inset (Lower right): Scatchard plot reveals 2 phases of 
binding. 
 
Fig. 3. His-Mms6 forms micelles.  His-Mms6 assembles into large multimers as 
shown by A) size exclusion chromatogram of His-Mms6 (0.2 mL of 1 mg/mL 
His-Mms6) from Superose 12 column and B) the sedimentation velocity profile of 
His-Mms6 and C) Dynamic light scattering.  D) His-Mms6 has a proteinase K 
resistant core. His-Mms6 and C21Mms6 were digested by proteinase K [His-Mms6: 
proteinase K = 10:1] for the indicated time periods then resolved by SDS-PAGE. The 
brackets identify the remaining protease-resistant protein fragments.  E) His-Mms6: 
liposome fusion characteristics are consistent with a micellar structure.  His-Mms6 
was incubated with and without liposomes and then incubated with proteinase K as 
identified on the figure. Legends above the figure and the added components listed 
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below the figure identify the conditions in each tube that deviated from the standard 
conditions, which were 20 mM Tris, 100 mM KCl, pH 7.5, 25 ℃? , and His-Mms6: 
Proteinase K = 4:1. The brackets identify the same protease-resistant fragments as in 
D.  The open arrowheads identify the protease-resistant band formed when the 
protein is associated with liposomes.  Dots represent the positions of different MM 
markers on the gel (from top to bottom: 25 kDa, 20 kDa, 15 kDa and 10 kDa) 
 
Fig. 4. C21Mms6 is structured. A. NMR spectra.  The 1H TOCSY (black) and 
NOESY (gray) spectra of C21Mms6 (850 µM) were determined in 5% (v/v) D2O, 
100mM KCl, pH 4. 9.  The results show distinct peaks in the NOESY spectrum that 
do not overlap with the TOCSY spectrum (The assignments of spectra and structure 
modeling are ongoing).  B. The dimeric apparent molecular mass of C21Mms6.  
The elution profile of C21Mms6 in 100 mM KCl, pH7.5 (Ο) or 50 mM sodium 
formate, 100 mM KCl, pH 3 () from a Superdex peptide 10/300GL column with a 
flow rate of 0. 4 mL/min at 4 ℃? .  Inset: The standard curve used to estimate the 
apparent molecular mass of C21Mms6 (standards: ▲, Log (MM): log of the 
molecular mass of the standards used).  The standards used to create this standard 
curve were: cytochrome C, aprotinin, insulin B chain (oxidized form) and vitamin 
B12 (Chromatograms are showed in Supplementary Fig. 8).  The elution profiles of 
the insulin B chain (oxidized form) and vitamin B12 were essentially the same under 
both buffer conditions. Neither cytochrome C nor aprotinin was stable at pH 3.  
 
71 
Fig. 5. Slow change in Mms6 structure with time after adding iron.  A) 
Fluorescence quenching in the N-terminal domain responds to iron binding by 
His-Mms6.  Inset: Emission spectrum of 5 µM His-Mms6 in the absence of iron or 
with 5, 15, 20, 100 µM ferric citrate (the arrow indicates the change in peak height 
with increasing concentration of ferric citrate).  His-Mms6 (5 µM) was incubated 
with ferric-citrate at concentrations ranging from 0 to 100 µM in 20 mM Tris-HCl, 
100 mM KCl, pH 7.5 in separate brown test tubes for 2 h at 25 ℃?  before the 
fluorescence measurements were taken.  B) A scatchard analysis of the data in A) 
that was used to obtain the Kdapp.  C) Slow change in fluorescence quenching after 
adding iron.  Shown are the averages of the results of five (His-Mms6) or four 
(His-m2Mms6) independent experiments with the standard deviations in which the 
values were first normalized to the value of the Fe3+-free sample of each 
experimental data set.  The resulting averages for His-Mms6 () and His-m2Mms6 
() were again normalized to the zero time value for each protein.  D) Slow change 
in the 1H-NMR spectrum after adding iron.  C21Mms6 (850 µM) was incubated for 
the indicated times with 1.7 mM ferric-citrate in 20 mM Tris, 100 mM KCl, 5% D2O 
(v/v), pH 7.5 followed by measurement of the spectrum by 1H-NMR.  
 
Fig. 6. Model for the mechanism of action of Mms6.  Based on the results 
discussed here, a model is proposed to describe the mechanism by which Mms6 can 
promote the formation of crystalline nanoparticles.  The N-terminus of the protein 
is seen as tethered in a micelle or a hydrophobic compartment such as a membrane. 
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The C-termini form minimal quaternary complexes of 2 domains (represented as a 
dimer of Mms6).  Upon binding ferric iron at very high affinity with a molar ratio 
of 1, the C-termini undergo a conformational change, coordinated with the 
N-terminal domain that initiates a slow rearrangement of the multiprotein complex to 
create a surface on which many iron atoms can organize.  This slow rearrangement 
allows the initiation of a crystal that is propagated on the protein surface to form a 
cluster of iron, which then becomes a crystal seed.  Mobility of Mms6 protein 
islands in the membrane or micelle is proposed to promote fusion of the crystal seeds 
to grow the magnetic nanoparticles. (Note: The mechanism of oxygen incorporation 
into the magnetite particles is not considered in this model). 
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Abstract 
Nature uses a bottom-up process to build the hierarchical structures in living 
organisms.  The sizes and morphologies of magnetites formed by magnetotactic 
bacteria are genetically defined and thus the consequence of the biomineralization 
protein(s).  The mechanism of this process remains elusive.  Here, we discussed 
our studies of Mms6 protein promoted magnetic nanoparticles formation.  We 
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observed that Mms6 undergoes a periodic structural change with increasing 
iron/protein ratio.  The observed structural change occurs in the N-terminal domain, 
but reflects iron binding by the C-terminal domain.  A mutant Mms6 that does not 
promote the formation of superparamagnetic magnetite also does not undergo the 
periodic structural change.  The correlation between the ability to form magnetic 
nanoparticles and the periodic structural change suggests that this structural change 
might participate in the mechanism of magnetite formation.  The C-terminal 
domain of Mms6 displays ferric reductase activity that is diminished in the mutant 
C-terminus.  Although it does not play a role in the in vitro formation of magnetite 
during which both ferrous and ferric forms of iron are provided, this reductase 
activity may participate in magnetite formation in vivo.   
Introduction 
Biomineralization is the process by which living organisms to form highly 
ordered mineralized structures with hierarchical structure at nanometer scales.  The 
mechanisms regarding biomineralization are poorly understood.  However, in those 
cases for which there is some understanding of the biological mechanisms involved 
in biomineralization, proteins have been found responsible for forming the mineral 
structures(1-3).  It has been proposed that the mechanism(s) involved in 
biomineralization may include the control of size, morphology, orientation, 
composition and the location of crystals synthesized (4).  The role of proteins in the 
biomineralization process is critical considering the physiological environments that 
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biomineralization occurs and the high temperatures and pressures required to achieve 
the same goals in vitro.    
Magnetotactic bacteria that can synthesize highly uniformed magnetic 
nanoparticles provide an ideal model for the studies of biomineralization process.  
Magnetotactic bacteria are aquatic prokaryotes which can migrate when oriented 
along local geomagnetic lines to find the optimal microaerobic environment to 
survive.  The magnetic nanoparticles are surrounded by magnetosomal lipid 
bilayers and aligned in chain(s), which provides the physical basis of the 
magnetotactic trait (5-9). 
Mms6 is a magnetosome membrane-associated protein.  Its mature form 
consists of 59 amino acids with a hydrophobic N-terminal half and a highly charged 
hydrophilic C-terminal half (10).  Recent studies have showed that deletion of 
Mms6 did not completely abolish the formation of magnetite particles, the particles 
formed by these mutant bacteria are smaller and of a different shape than in the wild 
type (11).  Although these results show that Mms6 may not be the only protein 
required to promote the formation of iron particles in magnetotactic bacteria, it has 
not yet been determined if the particles produced by the mutant bacteria have the 
same magnetic characteristics as the wild-type particles.  The possibility of gene 
redundancy may also complicate the interpretation of these results.  The exact 
function of Mms6 protein in vivo remains elusive, however its ability to promote the 
formation of magnetic nanoparticles in vitro is conclusive (10,12-14).  
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Here, we show that Mms6 undergoes periodical structural change upon iron 
binding.  Analysis of the quaternary structure of Mms6 protein and its C-terminal 
domain reveals that the C-terminal domain contributes to the overall stability of the 
quaternary structure of Mms6.  Magnetic property measurements of the 
nanoparticles that are produced in the presence of His-Mms6 and its C-terminal 
mutants further confirm that the ability to undergo structural changes is correlated 
with the function of Mms6 protein in vitro.  In addition, we show that the 
C-terminal domain of Mms6 displays iron reductase activity, which could be part of 
the mechanism of crystal packing that is promoted by Mms6. 
Experimental Procedures 
Materials— His-Mms6 and its mutants (His-m2Mms6 and His-m3Mms6) were 
expressed and purified as described previously (12,15).  The C-terminal domain of 
Mms6 (C21Mms6: KSRDIESAQSDEEVELRDALA) and its mutants (m2C21Mms6: 
KDRSIDEAQESDSVELREALA; m3C21Mms6: QSLERAEDEDADISAVEKLSR) 
were chemically synthesized by Genscript (Genscript Corp., www.genscript.com).  
Fluorescence spectroscopy— Tryptophan fluorescence of His-Mms6 was measured 
in a 96-well plates with a fluorescence spectrophotometer (Varian, Model: Cary 
Eclipse) at 25 ℃? , and at excitation and emission wavelengths of 290 nm and 340 
nm respectively.  In this assay, five µM His-Mms6 or His-m2Mms6 in 50 mM 
sodium formate, 100 mM KCl, pH 3 were mixed with or without FeCl3 at molar 
ratios of protein:FeCl3 from 1:1 to 1:23 (inclusive of all unit values) and monitored 
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by fluorescence (Ex: 290 nm, Em: 340 nm) after having been incubated at 25 ℃? for 
2 h. 
Size exclusion chromatography— Chromatography was performed with an AKTA 
FPLC system (GE healthcare) by passing the samples through a prepacked Superdex 
G75 10/300GL (separation range: 1 kDa-75 kDa) or Superdex Peptide 10/300GL 
column (separation range: 700 Da-20 kDa) (GE healthcare).  The elution profiles of 
His-Mms6, His-m2Mms6 and His-m3Mms6 were generated using a flow rate of 
0.4 mL/min at 4☆? through a Superdex G75 column and monitored by A280.  The 
elution profiles of C21Mms6, m2C21Mms6 and m3C21Mms6 were generated using 
a flow rate of 0.4 mL/min at 4 ℃?  through a Superdex Peptide 10/300GL column 
and detected by o-phtalaldehyde(16,17) (OPA, Thermo Scientific).  In this assay, 
200 µL of OPA was added to 20 µL of each fraction from gel filtration 
chromatography and the fluorescence of each sample was read in a 96-well plate by 
a fluorescence spectrophotometer (Varian, Model: Cary Eclipse), at excitation and 
emission wavelengths of 350 nm and 450 nm respectively.  All samples were 
centrifuged at 14,000 g, 4 ℃?  for 1 h before loading on the column. 
Blue dextran was used to determine the void column volume (Vo) of each 
column.  The elution volumes (Ve) of bovine serum album (MM 66 kDa), 
ovalbumin (MM 44.3 kDa), carbonic anhydrase (MM 29 kDa), myoglobin (MM 
17.6 kDa), aprotinin (MM 6.5 kDa) and B12 (MM 1355 Da) (all from Sigma) 
obtained by Superdex G75 10/300GL were used to generate the standard curve for 
the apparent molecular mass estimations of His-Mms6, His-m2Mms6 and 
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His-m3Mms6.  The elution volumes (Ve) of cytochrome c (MM 10.37 kDa, 
aprotinin (MM 6.5 kDa), insulin B chain oxidized form (MM 3495 Da) and B12 
(MM 1355 Da) (all from Sigma) from a Superdex Peptide 10/300GL column were 
used to generate the standard curve for the apparent molecular mass estimations of 
C21Mms6, m2C21Mms6 and m3C21Mms6.   
UV spectroscopy— The interaction between His-Mms6 and C21Mms6 was 
investigated by monitoring the absorbance change of His-Mms6 at A280 upon 
C21Mms6 addition at 25 ℃? . In this assay, His-Mms6 (40 µM) was mixed with 
C21Mms6 at molar ratios of His-Mms6: C21Mms6 from 0 to 1:10 for 1h followed 
by 15 min of centrifugation at 14000 g at 25 ℃? .  The absorbance at 280 nm of the 
resulting supernatants was then measured by spectrophotometer (Nanodrop, model: 
ND-100).   
Nuclear magnetic resonance (NMR) Spectroscopy— NMR analysis was performed 
on a Bruker AVII700 equipped with a 5 mm TCI cryoprobe.  All NMR analyses 
were performed at sample temperature of 25 ℃? .  2D 1H-1H TOCSY and NOESY 
spectra were collected using standard experimental protocols (Bruker pulse programs 
mlevgpgp19 and noesygpph19, respectively) with WATERGATE solvent 
suppression.  The TOCSY experiment consisted of 256 time increments of 8 scans 
each, with a total acquisition time of 43 min and MLEV17 mixing time of 80 ms.  
The NOESY experiment consisted of 512 time increments of 64 scans each, with a 
total acquisition time of 7.5 h and NOESY mixing time of 400 ms.  All NMR data 
were processed and analyzed using Bruker Topspin 2.1 software. 
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Ferric reductase assay— The ferric reductase assay was measured in 96-well plates 
aerobically at 25 ℃?  with a microplate reader (Bioteck Ceres 900C).The ferric 
reductase activities of C21Mms6 were measured by detecting the ferrous iron 
reduced from ferric iron using ferrozine.(18-20)  The assay mixture contained 0.1 
mM NADH, 25 µM or 75 µM ferric citrate, 1 µM flavin mononucleotide (FMN), 1 
mM ferrozine (all from Sigma) and 85 µM C21Mms6 in 20 mM Tris-HCl, 100 mM 
KCl, pH 7.5 in a total volume of 250 µL.  The reaction was initiated by addition of 
C21Mms6.  The increase of A562 was recorded every 2 min on a microplate reader 
(Biotek, Model: Ceres 900).  A mixture containing the same components (exclude 
C21Mms6) as the assay mixture was used as blank.  The concentration of ferrous 
iron was determined by A562 using extinction coefficient of 28 mM-1 cm-1.(21)  
The specific activity is expressed as nmol Fe2+ formed/min/mmol protein. 
Magnetic measurements— Magnetization measurements were carried out using a 
Quantum Design SQUID (Superconducting Quantum Interference Device) 5T 
MPMS (Magnetic Properties Measurement System). Specimens were cooled in zero 
magnetic field to 5K, a negative magnetic field of – 5T was applied and then 
reversed to 500 Oe to insure complete magnetization reversal in each particle and 
removal of any metastable states. Measurements were taken while warming the 
sample to 296K (ZFC-W process) and then on cooling back to 5 K (FC-C process). 
The blocking temperature was determined as a maximum on the ZFC-W curve. 
Transmission electron microscopy— Samples were imaged with a Tecnai G2 F20 
Scanning Transmission Electron Microscope (FEI Company, Hillsboro OR) 
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equipped with high angle annular dark field (HAADF) and energy dispersive X-ray 
spectroscopy (EDX) detectors at operating voltage 200 KV. Washed magnetites (20 
µL of aqueous suspension) were dispersed in 2 mL of ddH2O and 20 µl of this 
suspension was deposited on a carbon-supported electron microscopy copper grid.  
Results 
Mms6 undergoes periodically structural changes with increasing iron 
concentration.  Our previous studies have shown that His-Mms6 undergoes slow 
(over a period of hours) structural changes upon ferric iron binding.(15)  Here we 
further examined the effect of ferric iron on the structure of His-Mms6 by 
monitoring the tryptophan fluorescence quenching upon ferric iron binding.  There 
are two tryptophan residues in the N-terminal domain of Mms6 (W5 and W21) and 
quenching of tryptophan fluorescence was observed upon ferric iron binding.  A 
periodic tryptophan quenching profile was observed with respect to the molar ratio 
of iron to protein with a periodicity of 12 Fe3+/His-Mms6 (Fig. 1,■,●).  Fig. 1B 
shows the averaged results from 5 independent experiments for His-Mms6 (●) and 
His-m2Mms6 (○).  Although all experimental datasets show the same periodicity, 
the amplitude varies greatly and thus the standard deviation is large when all datasets 
are averaged.  We do not know the reason for this variability.  No significant 
change in fluorescence was observed with His-m2Mms6 (Fig. 1,□, ○).   
Ability to undergo structural changes correlates with the ability to form particles. 
To examine the possible significance of the periodic structural changes in Mms6 
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when binding iron, we determined the structure and magnetic properties of the 
magnetites formed in the presence of His-Mms6 and His-m2Mms6 (Fig. 2).  The 
results showed that crystals of about 30 nm in diameter were formed in the presence 
of His-Mms6 but not in the presence of His-m2Mms6 (Fig. 2 Inset). The blocking 
phenomenon (and its characteristic “blocking” temperature) is a signature of the 
superparamagnetic regime that depends on the particle size, degree of crystallinity 
and interparticle interactions. Below the blocking temperature, the random magnetic 
moments of individual nanoparticles cannot align with the applied field. The 
blocking temperature is reduced when the size or crystallinity of the the particles are 
reduced (11). The particles synthesized in the presence of His-Mms6 exhibited a 
blocking temperature (Fig 2, ☆?) typical of superparamagnetic particles compared 
with the lower blocking temperatures that characterized the particles produced in the 
presence of His-m2Mms6 (Fig 2, ▽?) and in the absence of protein (Fig 2, ●).   
C-terminal domain contributions to the overall stability of His-Mms6 quaternary 
structure.  Our previous studies showed that His-Mms6 forms a stable micellar 
quaternary structure in an aqueous environment (15).  From its primary sequence, 
which contains a large proportion of Leu-Gly repeats and hydrophobic amino acids 
(Supplementary Table.2), we speculate that the driving force for the formation 
micelles are hydrophobic and van der waals interactions.  However, we have also 
observed that the C-terminal domain, which is replete with hydrophilic amino acid 
side chains, also forms quaternary structures.  We used size exclusion 
chromatography to examine the contribution of the C-terminal domain to the 
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quaternary structure of His-Mms6.  Whereas the chromatogram of His-Mms6 
appeared as a single peak in the void volume of the column, the chromatograms of 
His-m2Mms6 and His-m3Mms6 both revealed multiple peaks on Superdex G75 
column (Fig. 3A).  The apparent molecular mass of the 3 peaks corresponded to 
multimeric (≥75 kDa), trimeric (~30 kDa) and monomeric (~10 kDa) forms of 
His-m2Mms6 (multimeric (≥75 kDa), dimeric (~20 kDa) and monomeric (~10 kDa) 
forms for His-m3Mms6).  When examined by denaturing (SDS) PAGE gel the 
samples from all the peaks migrated to the same position, thus confirming that all 
peaks on the column contained the same monomeric form of His-Mms6 mutants.  
To examine if the separated peaks of protein multimers are in equilibrium, the void 
volume samples for His-m2Mms6 and His-m3Mms6 were retrieved and run again 
through the column.  These rerun samples distributed similarly as multiple peaks 
when separated through the column for both (Supplementary Fig.9).  These results 
showed that the changes in the Mms6 C-terminal domain result in decreased stability 
of the overall quaternary micellar structure of Mms6. 
We further examined the structures of the 21 amino acid C-terminal domain of 
His-m2Mms6 and His-m3Mms6 (referred to here as m2C21Mms6 and m3C21Mms6 
respectively).  The elution profile of m2C21Mms6 and m3C21Mms6 also reveals 
multiple peaks (Fig. 3B, ◊, ●).  The apparent molecular mass corresponded to 
trimeric (~6.9 kDa) and dimeric (~4.6 kDa) forms of m2C21Mms6 (trimeric (~6.9 
kDa, dimeric (~4.6 kDa and monomeric (~2.3 kDa) forms for m3C21Mms6).  The 
NOESY spectrum of m2C21Mms6 revealed less non-sequential, inter-residue amide 
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to side-chain NOE cross peaks than that of C21Mms6 (Fig. 4) (the assignments of 
spectra and structural modeling of m2C21Mms6 are ongoing, Bruce Fulton, personal 
communication).   
If the C-terminal domain contributes to the overall quaternary structure of 
His-Mms6, we might be able to destroy that structure by interfering with the 
C-terminal domain interactions.  SDS-PAGE gel showed that when C21Mms6 and 
His-Mms6 were mixed, a precipitant containing His-Mms6 and C21Mms6 was 
formed (Supplement Fig 3).  To determine the stoichiometry, we titrated His-Mms6 
with C21Mms6. Increasing molar ratios of C21Mms6 to His-Mms6 resulted in 
graded precipitation of His-Mms6 starting after a molar ration of 3:1 
(C21Mms6:His-Mms6) with complete precipitation occurring at a ratio of 7:1 and 
above (Fig. 5).  These results show that the quaternary structure of His-Mms6 is 
disrupted by additional C21Mms6 with the outcome that the protein is no longer 
soluble.  Similar results were obtained when the C-terminal domain was cleaved 
from the protein with proteinase K.  Thus, we speculate that C21Mms6 may 
dislodge the C-terminal domain from its structural integration in the His-Mms6 
micelle and thereby expose the N-terminal hydrophobic core of the micelle to water.  
Another possible explanation is that the free C-terminus may act as a cross-linker of 
His-Mms6 micelles and promote the formation of higher ordered structures that 
precipitate.  The results suggest that each C-terminal domain of Mms6 can interact 
with 7 other C-terminal domains and therefore suggest that the C-terminal domain of 
Mms6 exists as an octamer on the surface of the micelle. 
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C21Mms6 has ferric reductase activity.  With the observation that Mms6 cannot 
bind ferrous iron to incorporate it into the growing magnetite crystals 
(Supplementary Fig. 10), we speculated that instead Mms6 may incorporate Fe2+ into 
the crystals by way of reducing bound Fe3+.  We observed that C21Mms6 has ferric 
reductase activity in an assay in which ferric citrate was the source of Fe3+ and 
NADH was the electron donor with the addition also of FMN (Fig. 6).  The specific 
reductase activity of C21Mms6 was determined to be 48.5±3.0 nmol Fe2+/min/mmol 
C21Mms6 (turnover rate: 14.3 days) and 128.6±8.9 nmol Fe2+/min/mmol C21Mms6 
(turnover rate: 5.4 days) when the ferric citrate concentration was 25 µM (Fig. 6A, ●) 
and 75 µM (Fig. 6B, ●) respectively.  The m2C21Mms6 had no reductase activity 
at 25 µM ferric-citrate (Fig. 6A, ○), but had some activity at 75 µM ferric citrate 
(59.0±6.0 nmol Fe2+/min/mmol m2C21Mms6, turnover rate: 17.8 days) (Fig. 6B, ○).  
To establish that the reductase activity observed in these experiments reflects a 
specific property of the Mms6 C-terminal domain, we tested m3C21Mms6 under 
these experiment conditions and found no activity at either concentration of iron (Fig. 
6 ■). 
Discussion 
In our previous studies, we reported that, in aqueous solution, Mms6 forms a 
micellar quaternary structure that has two phases of iron binding; a stoichiometric 
high affinity binding phase and a high capacity but low affinity binding that is 
cooperative with respect to iron concentration (15).  Here, we further investigate 
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the relation between quaternary structure of Mms6 and the ability of this protein to 
promote the formation of superparamagnetic magnetite particles.   
An important driving force for the formation of His-Mms6 protein micelle is 
likely to be the hydrophobic interactions as it is evident that the primary sequence of 
Mms6 protein contains a large portion of Leu-Gly repeats and hydrophobic amino 
acids.  Our previous studies showed that the quaternary structure of Mms6 to be a 
bipolar micellar structure with the C-terminal domain exposed on the surface of the 
molecule (15).  The results of titration of the C-terminal domain with C21Mms6 
suggests that this domain may interact on the surface of the micelle as an octamer 
and that disrupting the surface interactions of adjacent C-terminal domains by an 
external domain destabilizes the quaternary structure of the multimer resulting in its 
precipitation.  Coincidently, similar observations have been made with amelogenin 
which is responsible for the biomineralization of enamel (22,23).  
Following up on our observation that Mms6 undergoes a slow structural change 
on binding iron, we investigated the effect of molar ratio of iron on the Mms6 
structure and discovered curious periodic relationship with the periods extending 
over a 12 molar units of iron to Mms6.  Although we do not yet understand the 
molecular basis for this structural change, we note that the periodic relation is a 
multiple of three and that the high capacity iron binding activity of Mms6 is 
cooperative with respect to iron and with a Hill value of 3.  Thus, an iron to Mms6 
ratio of three might be the minimal grouping by which the protein incorporates iron 
into a magnetite crystal.  This number is also compatible with the magnetite iron 
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composition, which is iron II:III in a 1:2 ratio. From these deductions, we speculate 
that Mms6 might bind iron in a 3:1 ratio of iron:Mms6 and with this grouping Mms6 
reduces one of the iron atoms. The structural change of Mms6 returns to the original 
condition at a ratio of iron:Mms6 of 12, which could involve 4 sets of 3 iron 
molecules incorporated into a growing magnetite crystal by an octamer of the 
C-terminal domain.  The periodic change in environment of the N-terminal 
tryptophan(s) as iron is added to the protein may reflect a rotation of the protein as it 
incorporates iron into a crystalline structure.  
Although we observed the reductase activity with the isolated C-terminal 
domain of Mms6, this peptide cannot form magnetic particles without being linked 
to the N-terminal domain or a polymer that forms a micelle (13).  Even without 
these linkages C21Mms6 interacts as a dimer.  However, in the context of the 
N-terminal domain we have observed that this protein is a multimer and speculate 
that the multimer is the functional unit for the formation of magnetite.  Our 
evidence suggests that both the N- and the C-terminal domains contribute to 
maintaining the structure of the multimeric form of Mms6, which is a micelle in 
aqueous solution, but could exist as islands of interacting proteins in a bacterial 
membrane.   
The surface fluorescence measurements show that His-Mms6 and His-m2Mms6 
selectively binds ferric iron not ferrous iron (Supplementary Fig. 10).  The 
observation led us to examine the C-terminal domain for ferric reductase activity and 
we observed that the C-terminal domain (C21Mms6) of Mms6 has ferric reductase 
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activity and that m2C21Mms6 also shows some reductase activity, although at 
higher ferric iron concentration.  These results suggest that the high affinity binding 
of iron is important for organizing C21Mms6 structurally so as to bring the 
appropriate amino side chains into position to form that catalytic site of this 
reductase.  Shuffling the positions of the –COOH and –OH groups as was done for 
m2Mms6 left this protein with a lower affinity for iron, which is consistent with the 
observation that a higher concentration of iron is required for catalytic activity.  
Implicit in this interpretation is the expectation that the critical residues that form the 
active reductase catalytic site are not those residues that were shuffled in 
m2C21Mms6 and that even the low affinity binding of iron to the debilitated iron 
binding site results in a structure that supports catalytic activity in m2C21Mms6.  
The observation of reductase activity suggest that reduction of ferric iron may be 
part of the mechanism of magnetite formation by Mms6 as previously proposed (24).  
An important finding in this study is the correlation between the ability of Mms6 
to undergo periodic structural changes and the ability to template the formation of 
magnetic nanoparticles.  High-resolution transmission electron microscopy of the 
iron oxy-hydroxide crystals formed by iron-oxidizing bacteria revealed that the 
mechanism of the crystals formation involves the aggregation of adjacent 2-3 nm 
particles followed by the orientation of these particles to parallel in three dimensions 
(25).  The sizes and shapes of crystals formed by magnetotactic bacteria are 
genetically defined and thus the consequence of the biomineralization protein(s) 
(26-29).  Knockout bacteria that lack Mms6 gene produce altered crystal shapes.  
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Our results suggest that the iron binding properties and quaternary structure of 
Mms6 is responsible for formation of the cubo-octahedral crystal structures of 
Magnetospirillum magneticum strain AMB-1.  We speculate that biomineralization 
proteins from magnetotactic bacteria that form different crystal structures might 
adopt different quaternary structures.  However, the possession of a quaternary 
structure and the ability of that structure to change as iron is incorporated into a 
crystal, may be more fundamental aspects of the mechanism by which a small 
protein such as Mms6 can promote the formation of magnetite crystals that are 
10-fold larger.   
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Figure Legends 
Fig. 1. His-Mms6 undergoes periodical structural change. A) The two 
independent representative results for His-Mms6 (■，?●) and His-m2Mms6 (□,○).  
The fluorescence values were normalized to the value of Fe3+-free sample of each 
data set.  B) The averaged results from 5 independent experiments for His-Mms6 
(●) and His-m2Mms6 (○). 
 
Fig. 2. His-Mms6 promotes the formation of superparamatic nanoparticles. 
Shown are the magnetization measurements of particles synthesized in the presence 
of His-Mms6 (☆?)，?His-m2Mms6 (▽?) or no-protein (●).  Inset: TEM images of 
particles synthesized in the presence of His-Mms6, His-m2Mms6 or no-protein. 
 
Fig. 3. C-terminal domain contributes to the overall His-Mms6 quaternary 
structure. A) The elution profile of His-Mms6, His-m2C21Mms6 and 
His-m3C21Mms6 in 20mM Tris-HCl, 100 mM KCl, pH7.5 from a Superdex G75 
10/300GL column with a flow rate of 0.4 mL/min at 4 ℃? .  B) The elution profile of 
C21Mms6 (□), m2C21Mms6 (◊) and m3C21Mms6 (●) in 100 mM KCl, pH7.5 from 
a Superdex peptide 10/300GL column with a flow rate of 0.4 mL/min at 4 ℃? . 
 
Fig. 4. Altered structure of m2C21Mms6.  A) The Overlay of the 1H NOESY 
spectra of C21Mms6 (grey) and m2C21Mms6 (black) spectra in 5% (v/v) D2O, 
100mM KCl, pH 4.9. B) The overlay of The 1H TOCSY spectra of C21Mms6 (grey) 
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and m2C21Mms6 (black) spectra in 5% (v/v) D2O, 100mM KCl, pH 4.9 (The 
assignments of spectra and structural modeling of m2Mms6 are ongoing). 
  
Fig. 5. C-terminal domain of Mms6 exists as an octamer on the surface of the 
micelle.  Shown is the titration curve of 40 µM His-Mms6 in 20 mM Tris-HCl, 100 
mM KCl, pH 7.5 titrated with C21Mms6. The absorbance of the supernatant was 
normalized to 40 µM His-Mms6. 
 
Fig. 6. C21Mms6 exhibits ferric reductase activity.  Shown are progress curves 
of ferric reduction catalyzed by C21Mms6 (●), m2C21Mms6 (○) and m3C21Mms6 
(■) when ferric citrate concentration was 25 µM (A ) and 75 µM (B).  
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CHAPTER 4: GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
General conclusions 
Here we report structural and functional studies of Mms6, a biomineralization 
protein that can promote the formation in vitro of magnetic nanoparticles with sizes 
and morphologies similar to the magnetites synthesized by magnetotactic bacteria.  
We found the binding pattern of Mms6 to ferric ion to be two-phase and multivalent.  
We quantatively determined that Mms6 binds one Fe3+ with a very high affinity (Kd 
= 10-16 M).  The second phase of iron binding is multivalent and cooperative with 
respect to iron with a Kd in the µM range and a stoichiometry of about 20 ferric ion 
per protein molecule.   
We found that Mms6 exists in large particles of two sizes, one consisting of 
20-40 monomeric units and the other of 200 units.  From proteolytic digestion, 
ultracentrifugation and liposome fusion studies, we found that Mms6 forms a large 
micellar quaternary structure with the N-terminal domain self-assembling into a 
uniformly sized micelle and the C-terminal domain on the surface.  
The two-phase iron-binding pattern may be relevant to iron crystal formation.  
We propose that the first high affinity phase may stabilize a new conformation of the 
C-terminal domain that allows interaction with other C-terminal domains leading to 
a structural change in the multimeric protein complex that enables the second low 
affinity iron binding phase to organize iron and initiate crystal formation. 
We also observed a dimeric apparent molecular mass of the Mms6 C-terminal 
peptide (C21Mms6).  We speculate that the C-terminal domain may form higher 
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order quaternary arrangements on the surface of the micelle or when anchored to a 
membrane by the N-terminal domain.  The change in fluorescence quenching in the 
N-terminal domain with iron binding suggests a structural integrity between the C- 
and N-terminal domains.  The slow change in trp fluorescence as a function of time 
after adding iron suggests a very slow conformational change in the protein that 
involves both N- and C-terminal domains.  We interpret these results to mean that 
there is a coordinated global change in Mms6 structure that involves multiple Mms6 
monomers. 
Based on our observations, we propose a mechanism by which Mms6 can 
promote the formation of crystalline nanoparticles.  Upon binding ferric iron at very 
high affinity with a molar ratio of 1, the C-terminal domains undergo a 
conformational change, coordinated with the N-terminal domain that initiates a slow 
rearrangement of the multiprotein complex to create a surface on which many iron 
atoms can organize.  This slow rearrangement allows the initiation of a crystal that 
is propagated on the protein surface to form a crystal seed.   
We also observed that Mms6 undergoes a periodical structural change with 
increasing molar ratios of iron to protein.  The observed structural change occurs in 
the N-terminal domain, but reflects iron binding by the C-terminal domain.  A 
mutant Mms6 that does not promote the formation of superparamagnetic magnetite 
also does not undergo the periodic structural change.  The correlation between the 
ability to form magnetic nanoparticles and the ability to undergo the periodic 
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structural change suggests that this structural change might participate in the 
mechanism of magnetite formation.   
Analysis of the quaternary structure of Mms6 protein and its C-terminal domain 
reveals that the C-terminal domain contributes to the overall stability of the 
quaternary structure of Mms6.  The C-terminal domain of Mms6 displays ferric 
reductase activity that is diminished in the mutant C-terminus.  Although it does not 
play a role in the in vitro formation of magnetite during which both ferrous and ferric 
forms of iron are provided, this reductase activity may participate in magnetite 
formation in vivo.   
 Our results suggest that the iron binding properties and quaternary structure of 
Mms6 is responsible for formation of magnetic nanoparticles.  The ability for 
Mms6 protein to form a quaternary structure and the ability of that structure to 
change as iron is incorporated into a crystal may be fundamental aspects of the 
mechanism by which a small protein such as Mms6 can promote the formation of 
magnetite crystals. 
Future directions 
 Biomineralization has been a hot topic for decades while its mechanism remains 
elusive.  The studies presented here are just a beginning towards fully 
understanding protein-promoted magnetic nanoparticle formation.  Some critical 
questions remain to be answered. 
 The His-tagged recombinant form of Mms6 used in this study may cause some 
misinterpretation regarding the results, so it will be desirable to obtain the Mms6 
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without His-tag.  In this regard, a C-terminal His-tagged recombinant form of 
Mms6 might be a good choice because the C-terminal domain of Mms6 protein is 
expected to be easy accessible to proteases. 
 The model presented here needs further testing.  The question of whether the 
overall structural change is caused by the high affinity binding to iron or the 
cooperative binding to iron remain to be answered.  In this regard, it is necessary to 
identify the binding sites responsible for the high affinity binding to iron by 
site-directed mutagenesis.  
 The correlation between the slow and periodic structural changes of Mms6 and 
the ability to promote the formation of magnetic nanoparticles needs to be 
investigated.  Because Mms6 forms large protein micelle, solid state nuclear 
magnetic resonance spectroscopy will be the ideal technique to use.  It will be 
interesting to see whether these changes in Mms6 structure reflect a process of 
orienting bound iron clusters to certain positions or angles that promote the 
formation of magnetites with specific morphologies. 
 The ability of Mms6 to template the formation of magnetic nanoparticles is 
amazing.  Cobalt ferrite has also been successfully synthesized in the presence of 
Mms6.  It will be interesting to determine if Mms6 promotes the formation of other 
metal nanoparticles such as Ru, Mn or Ni.  
 The reductase activity of Mms6 protein is another interesting aspect worth 
exploring.  In this regard, an alanine scan of the –OH and –COOH groups in the 
C-terminal domain of Mms6 will be useful to identify the residues responsible for 
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the reductase activity.  It will be interesting to see whether the groups responsible 
for the reductase also participate in the high affinity iron binding. 
 Both the C-terminal domain and His-Mms6 show reductase activity.  However, 
the nature of the His-Mms6 reductase activity is as yet not fully understood because 
in some cases the activity appears hysteretic, being delayed in time in its appearance 
after the addition of iron, and in other cases the activity begins immediately after 
adding iron.  Thus, the reductase activity of Mms6 needs to be fully characterized.    
Conditions such as pH and buffer components used in the experiment need further 
optimization and different electron donors (such as NADPH) and cofactors (if any is 
required) should be tested.  The enzymatic constants, such as Km and Vm, need to 
be determined.  The inhibitory effect of another metal irons, such as Ni, Ca or Co 
need to be examined.  It will be interesting to see whether factors that inhibit the 
reductase activity will also inhibit the formation of magnetic nanoparticles. 
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SUPPLEMENTARY FIGURES AND TABLES 
Fig 1: His-Mms6 forms monolayer at the liquid-air interface.  The surface 
pressure isotherms of His-Mms6 were measured by a Langmuir-Blodgett trough 
(Type611, Nima Technology).  The His-Mms6 protein sample (2.36 µg) was 
directly added onto the surface of 500 ml of buffer, which containing 20 mM 
Tris-HCl, 100 mM KCl, pH 7.5 or pH 3 at 25 ℃?  hold by the trough.  The surface 
pressure isotherms were then measured with a compression speed of 10 cm2/min.  
His-Mms6 forms a monolayer at the liquid-air interface on a buffer containing 20 
mM Tris, 100 mM KCl, pH 7.5 (solid line) or pH 3 (dash line).  When the 
monolayer is compressed, the surface pressure is increased.  The increase of the 
surface pressure due to individual protein molecules making contact can be used to 
estimate the molecular area (1-4).  The molecular area can be obtained by dividing 
the surface area at which the increase in surface pressure observed by the number of 
molecules spread on the surface.  The molecular area was about 8000 Å2 at both 
pHs.  The ability of His-Mms6 to form a monolayer at both pH 7.5 and pH 3 
indicates that the quaternary structure of His-Mms6 is a micelle and not protein 
aggregates (5,6). 
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Fig 2: C21Mms6 runs as a monomer in 6 M GnCl (guanidine hydrochloride). 
Shown are the standard curve (A) used to estimate the apparent molecular mass of 
C21Mms6 in 20 mM Tris, 100 mM KCl, 6 M GnCl, pH 7.5 and the chromatogram 
(B) of the samples used.  Blue dextran was used to determine the void column 
volume (Vo) of the Superdex Peptide 10/300GL column (separation range: 700 
Da-20 kDa).  The elution volumes (Ve) of cytochrome c (MM 10.37 kDa, aprotinin 
(MM 6.5 kDa), insulin B chain oxidized form (MM 3495 Da) and B12 (MM 1355 
Da) (all from Sigma) from a Superdex Peptide 10/300GL column run at 0.4 mL/min, 
4℃?  were used to generate the standard curve for the apparent molecular mass 
estimations of C21Mms6 (○: Standard used; ▲: C21Mms6; The linear regression 
formula used for MM estimation was Y=-1.54X+5.65).  The C21Mms6 doesn’t 
have trp, tyr or phe in its sequence.  GnCl interferes with the OPA reagent, which 
fluoresces when bound to primary amines.  So the elution volume of C21Mms6 in 
6 M GnCl was identified by PAGE each fraction through a 15 % gel in the presence 
of 0.1 % SDS. 
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Fig 3: C21Mms6 interacts with His-Mms6.  Shown is the SDS-PAGE gel of 40 
µM His-Mms6 incubated with or without 800 µM of C21Mms6 in 20 mM Tris, 100 
mM KCl, pH 7.5 at 25 ℃?  for 1 h followed by centrifugation at 14000 g for 15 min. 
M: Protein Marker (from top to bottom: 54 kDa, 42 kDa, 34 kDa, 26 kDa, 17 kDa, 
10 kDa). S: Supernatant. P: Pellet.  The gel shows that when mixed with C21Mms6, 
both His-Mms6 and C21Mms6 were found in the pellet (right panel).  His-Mms6 
alone did not precipitate under the same experimental conditions (middle panel).  
His-Lcn2 which has the same His-tag as His-Mms6 was used as control and no 
precipitation was found.  These results indicate that the precipitation of His-Mms6 
was caused by the interaction between free C21Mms6 and Mms6 (probably the 
C-terminal domain of Mms6) and not with the His-tag. 
 
 
Fig 3 
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Fig 4: Analytical ultracentrifugation (raw data). One half mL of 0.46 mg/mL 
(A280=0.702) His-Mms6 in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,1.4 mM 
KH2PO4, pH 7.2 was loaded into the cell and placed in an AN60 rotor in a Beckman 
Proteome Lab XL-A Protein Characterization System (Beckman) for centrifugation.  
The time-dependent sedimentation of His-Mms6 was monitored at 280 nm, 65,520 x 
g, 4℃?  for 2 h.  
  
  
Fig 4 
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Fig 5: Comparison of the binding of ferric citrate for His-Mms6 and 
His-m3Mms6 measured by fluorescence spectroscopy.  His-Mms6 (5 µM, ) or 
His-m3Mm6 (5 µM, ) was incubated with ferric-citrate at concentrations ranging 
from 0 to 100 µM in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 in separate brown test 
tubes for 2 h at 25 ℃?  before the fluorescence measurements were taken (Ex:290 nm, 
Em: 345 nm). 
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Fig 6: Size exclusion of His-Mms6 under denaturing condition.  The quaternary 
structure of His-Mms6 appears quite stable as suggested by the size exclusion 
chromatography under denaturing condition. Shown are the chromatograms of 1 mL 
of His-Mms6 (0.5 mg/mL) in 4 M urea (A) or 6 M GnCl (B) run through Superdex 
G75 column with a flow rate of 0.4 mL/min. The chromatograms of BSA and ferritin 
in 6 M GnCl were used for comparison.  Some of the His-Mms6 still exhibited 
large apparent molecular mass and appeared in the void volume of the Superdex G75 
column in 4 M urea (A) or 6 M GnCl (B), 20 mM Tris, 100 mM KCl, pH7.5.  
 
 
Fig 6 
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Fig 7: Enterokinase cleavage of His-Mms6 in the presence of detergent or under 
denaturing conditions.  Shown are the SDS-PAGE analyses of His-Mms6 after its 
incubation with enterokinase (rEK) for 24 h in different buffer conditions (1xrEK 
cleavage buffer: 20mM Tris-HCl, 50mM NaCl, 2mM CaCl2).  Under these 
conditions, a slight shift of the His-Mms6 band was observed (A) but the western 
blot result (B: His-Mms6 after enterokinase cleavage detected by western blot.  
Lane 1,2,3 are samples of lane 2,3,4 in A respectively) indicated that the shifted 
bands have the His-tag still present. Two other proteins (His-Utc and His-EXFABP) 
which have the same His-tag and enterokinase cleavage site as His-Mms6 were used 
as controls to show that under these conditions the enterokinase can cleave the 
His-tag if the cleavage site is accessible (C).  
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Fig 8: Chromatograms of standards used in Fig 4B inset (chapter 2) 
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Fig 9: Chromatograms of the rerun of the void volume of His-m2Mms6 and 
His-m3Mms6 from Superdex G75 column (Fig. 3A, chapter 3). A: His-m2Mms6. 
B: His-m3Mms6. 
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Fig 10: His-Mms6 specifically binds Fe3+ not Fe2+ (Data from Wenjie Wang and 
David Vaknin).  Ferric chloride hexahydrate (FeCl3·6H2O) and ferrous chloride 
tetrahydrate (FeCl2·4H2O) each in 20 mM Tris, 100 mM KCl, pH 3 was used as the 
Fe3+ and Fe2+ bulk solutions respectively.  Prior to taking X-ray measurements, an 
isotherm, in which the film was compressed at rate of 1Å2 per molecule per min in a 
Langmuir trough maintained at 20°C, was determined in order to make the film 
maximally compact.  X-ray studies were carried out on the Ames Laboratory Liquid 
Surface Diffractometer at Advanced Photon Source (APS, 7.3 KeV).  A beam of 
monochromatic x-ray selected by a downstream Si double crystal monochromator is 
deflected onto the liquid surface to a desired incident angle αi by a second 
monochromator Ge (111).  When the incident angle αi is less than the critical angle 
for total external reflection, the x-ray penetration depth is ~60Å at the most. Also the 
photon energy of x-ray is sufficient to excite Fe elements to fluoresce (Kα and Kβ).  
The x-ray fluorescence intensity from the film was collected by a Vortex energy 
dispersive detector (EDD) at scattering vector Qz ranging from 0.01 Å-1 to 0.03 Å-1 
(Qz=4±sinαi/λ, λ being x-ray wavelength). Shown are fluorescence signals below 
the critical angle for 10−3 M FeCl3 (☆?) or 10−3 M FeCl2 (○) with the His-Mms6 
monolayer.  The signals were integrated over a Qz range as indicated in the figures. 
The results suggested that His-Mms6 specifically binds Fe3+ not Fe2+. 
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Table 1: The retention efficiency of His-Mms6 by nitrocellulose membranes.  
To check how much protein was captured by the 0.45 µm nitrocellulose membrane, 
500 µL of 20 µM His-Mms6 in 20 mM Tris, 100 mM KCl, pH 3 was filtered through 
0.45 µm nitrocellulose membranes followed by two consecutive 5 mL volumes of 
wash with 20 mM Tris, 100 mM KCl, pH 3.  The flow through was collected and 
concentrated to 500 µL.  The concentration of His-Mms6 was measured by A280. 
The retention efficient of His-Mms6 hold by the membrane was determined to be 89 
% ±2 %. 
Table 1 
 
Before filter by 
membrane 
(volume: 0.5mL) 
Flow through 
(volume:0.5mL) 
Retention 
efficiency 
(%) 
Average 
(%) 
Standard 
deviation 
(%) 
0.308 0.033 89 
0.291 0.026 91 A280 
0.287 0.037 87 
89 2 
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Table 2: N-terminal sequencing of the precipitate after proteinase K digestion of 
His-Mms6 for 24 h (Chapter 2, Fig. 3D, middle panel). The sample was 
centrifuged at 14000 g for 1hr.  The pellet was then collected and resolved by 
SDS-PAGE gel and transferred to membrane. The band was cut and sent for 
N-terminal sequencing. 
 
Sequence of His-Mms6 (Bold italic: mature Mms6 sequence): 
GGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLGGHMVGGTIWTGK
GLGLGLGLGLGAWGPIILGVVGAGAVYAYMKSRDIESAQSDEEVELRDAL
A 
 
Table 2 
Cycle # Amino Acid 
1 G,D,Y 
2 A,W,L 
3 W,G, 
4 A, 
5 W,V 
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